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RÉSUMÉ 
Introduction: La stomatite prothétique est une condition inflammatoire chronique de la 
muqueuse buccale recouverte par une prothèse. Cette maladie est considérée comme la 
lésion buccale la plus fréquente chez les porteurs de prothèses amovibles. Des études 
récentes sur l'étiologie de la stomatite prothétique suggèrent que des traitements basés 
sur la réduction de l'inflammation seraient efficaces dans le traitement de cette maladie. 
Objectifs: Évaluer l'efficacité du brossage du palais dans le traitement de la stomatite 
prothétique. 
Méthodes: Quarante-huit participants (âge moyen : 66,0 ± 11,2 ans) avec un diagnostic 
de stomatite prothétique, ont été sélectionnés à partir d’un examen préalable de 143 
individus, afin de participer à cet essai clinique de phase I à deux centres, réalisé selon 
un devis de type pré-test/post-test à un seul groupe. L'intervention a consisté en un 
brossage du palais avec une brosse manuelle après chaque repas et avant le coucher. 
Des examens cliniques et microbiologiques ont été effectués avant le traitement, et à 1 
mois et 3 mois de suivi. Des données supplémentaires ont été obtenues par l'utilisation 
d'un questionnaire validé. Les résultats primaires et secondaires étaient, respectivement, 
la rémission de stomatite prothétique et la diminution du nombre de colonies de 
Candida. Des tests statistiques descriptifs et non paramétriques ont été menés pour 
analyser les données. 
Résultats: À 3 mois de suivi, 10,4 % des participants ont été guéris et 70,8 % ont eu 
une amélioration clinique de la stomatite prothétique grâce au brossage du palais. Une 
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réduction statistiquement significative de la surface et de l’intensité de l’inflammation 
après 3 mois de brossage du palais a été démontrée (p < 0,0001). L’ampleur de l’effet a 
varié d’un effet modéré à important (0,34 à 0,54) selon la classification utilisée pour le 
diagnostique de la stomatite prothétique. De plus, le nombre de colonies de Candida, 
recueillies par sonication des prothèses et par échantillonnage du palais, a diminué de 
manière statistiquement significative après 3 mois de brossage (p ≤ 0,05). 
Conclusion: Les résultats de cette étude suggèrent que le brossage du palais est efficace 
comme traitement de la stomatite prothétique.  
Mots-clés: Stomatite prothétique, brossage du palais, prothèse complète, Candida, 
étude de phase I. 
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ABSTRACT 
Introduction: Denture-related erythematous stomatitis (denture stomatitis) is a chronic 
inflammation of the oral mucosa covered by a removable prosthesis. This disease is 
considered the most prevalent mucosal lesion associated with prosthesis use. Recent 
research on the etiology of denture stomatitis suggests that treatments based on the 
reduction of the inflammation are effective in the management of this disease.  
Objectives: To assess the efficacy of palatal brushing in the treatment of denture 
stomatitis. 
Methods: After screening 143 individuals with a potential diagnosis of denture 
stomatitis, 48 (mean age: 66.0 ± 11.2 years) were enrolled in a phase-I two-center 
clinical trial with one-group pre-test/post-test design. The intervention of interest was 
manual palatal brushing after each meal and before bedtime. Clinical and 
microbiological examinations were performed at baseline, 1 month and 3 months post-
intervention. Additional data were obtained by the use of a validated questionnaire. The 
primary and secondary outcomes were the remission of denture stomatitis and the 
diminution of Candida Colony-Forming Units (CFUs), respectively. Descriptive and 
non-parametric statistical tests were conducted to analyze the data. 
Results: At 3-month follow-up, denture stomatitis was completely cured in 10.4 % of 
the study participants, and 70.8 % of denture wearers showed improvement in the 
clinical signs of denture stomatitis. There was a significant reduction in the area and 
severity of the palatal inflammation at 3-month follow-up (p < 0.0001). The effect size 
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ranged from medium to large (0.34 to 0.54), depending on the classification used for 
the diagnosis of denture stomatitis. Furthermore, a significant reduction in the number 
of Candida CFUs isolated from the palatal mucosa and dentures was observed (p ≤ 
0.05). 
Conclusion: The results of this study suggest that palatal brushing is effective in the 
treatment of denture stomatitis. 
Keywords: Denture stomatitis, palatal brushing, complete denture, Candida, phase I 
trial 
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CHAPTER I 
LITERATURE REVIEW 
1.1 INTRODUCTION 
Over the last few decades, there has been substantial progress in understanding the role 
of oral inflammation in systemic health. Oral inflammation is a protective, non-specific 
response of the immune system to a pathogenic or traumatic injury 
1-3
. Although this 
defensive inflammatory mechanism is necessary for the protection of the oral cavity, it 
can be potentially deleterious when it becomes long-lasting and persistent.   
Denture-related erythematous stomatitis (denture stomatitis) is the most common 
mucosal disease associated with the wear of removable prostheses, and is characterized 
by a chronic inflammation of the palatal mucosa 
4-6
. The treatment of this recurrent 
condition has challenged clinicians because of its resistant and refractory nature. 
Although its recalcitrance has been related to Candida biofilms and their attachment to 
prosthetic surfaces, the direct role of Candida in the injury to the adjacent mucosa has 
been questioned. The new evidence suggests that trauma initiates the inflammatory 
reaction in denture stomatitis 
7
. Subsequently, the complex structured microbiological 
communities play an intermediary role in the process of denture stomatitis 
7
. Based on 
this hypothesis, the treatment of denture stomatitis should focus on the resolution of the 
inflammation.  
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The first chapter of this thesis will review the literature to discover the rationale behind 
this hypothesis.  
1.2 ORAL INFLAMMATION 
1.2.1 Definition of oral inflammation  
The oral cavity is a very complex system that is vulnerable to inflammatory diseases due 
to the exposure of the oral environment to different pathogenic stimuli. Although the 
primary role of an inflammatory response is to protect oral tissues from a deleterious 
injury 
1, 3
, this defensive mechanism could affect different sites of the oral cavity and 
manifest as a primary sign of oral diseases such as periodontitis, pulpitis, mucositis, and 
stomatitis 
8
.  
Inflammation is defined as a nonspecific response of the body in reaction to a 
mechanical, chemical or microbial stimulus 
9
. Its etymology comes from the Latin 
inflammare, “to set on fire”. Cornelius Celsus 10, a Roman encyclopaedist, was the first 
person who introduced the cardinal signs of inflammation. These include redness, 
swelling, heat and pain, and represent the clinical manifestation of increased local 
vascularity, exudation of tissue fluid, increased blood flow and the release of 
inflammatory mediators, as well as the stimulation of pain receptors 
1, 3
. In 1858, Rudolf 
Virchow added loss of function to the four signs of inflammation. Loss of function is 
caused by the combination of pathophysiological events that occur during inflammation 
11
. 
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1.2.2 Physiology of oral inflammation 
An oral inflammatory process is similar to any other inflammation in the human body 
and consists of complex interactions between inflammatory mediators and different 
types of cells 
1, 3
. Inflammatory mediators are soluble molecules that represent the 
physiological messengers of the inflammation and can positively or negatively influence 
the inflammatory process 
7, 12
. Their role is to induce and maintain a host response. 
Inflammatory mediators include vasoactive amines (histamine, serotonin), arachadonic 
acids (prostaglandins, leukotrienes) and cytokines (tumor necrosis factor, interleukins, 
interferons, and colony stimulating factors). Those mediators are released from different 
types of cells, including mast cells, dendritic cells, platelets, neutrophils and monocytes 
1, 9
.  
Inflammatory mediators initiate numerous physiological processes including 
vasodilatation, increased microvascular permeability, cellular activation, cellular 
adhesion, and coagulation. Vasodilatation and increased microvascular permeability at 
the site of injury increase the available oxygen and nutrients, generate heat, and provoke 
tissue oedema. This increased permeability leads to the infiltration of plasma proteins 
and leucocytes from the circulation. The leucocytes, which consist principally of 
polymorphonuclear leukocytes (neutrophils) and macrophages, are attracted by 
inflammatory mediators, become activated, and aggregate at the site of the injury. They 
also become engaged in the production of cytokines and other inflammatory mediators 
3, 
13
. Endothelial cells also become active and secrete additional cytokines and secondary 
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inflammatory mediators. These processes result in the activation of coagulation 
cascades and lead to local thrombosis and isolating of the inflamed areas 
9
. 
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Figure 1.1: The inflammatory process 
INFLAMMATORY 
RESPONSE  
RELEASE OF INFLAMMATORY 
MEDIATORS  
Vasodilatation and ↑ 
microvascular permeability 
 
↑ Oxygen, 
nutrients, 
heat and 
oedema 
 
Chemical attraction 
and infiltration of 
plasma proteins and 
leucocytes 
Activation and aggregation 
of leucocytes at the site of 
injury + production of 
additional inflammatory 
mediators 
Activation of 
endothelial cells 
Secretion of additional 
mediators and 
activation of 
coagulation cascade 
 local thrombosis 
Resolution of the 
inflammation 
OUTCOMES  
STIMULI 
MECHANICAL, CHEMICAL OR 
MICROBIOBIAL 
 
 
Fibrosis 
Abscess 
formation 
Chronic 
inflammation 
 6 
 
 
1.2.3 Types and etiology of oral inflammation 
An oral inflammatory response can be classified into two main types: acute and chronic 
inflammation. An acute inflammatory response is a process characterized by a rapid 
onset, usually appearing within a few minutes or hours after the injury. This prompt 
response is also of short-term duration and ceases after the removal of the stimulus 
3
. 
Acute inflammation is marked by the exudation of fluid and plasma proteins and by the 
migration of leukocytes, most particularly neutrophils, to the site of injury 
1
. Conversely, 
a chronic inflammatory response is of prolonged duration and is characterized by the 
presence of lymphocytes and macrophages. Chronic inflammation could result from 
failure to eliminate the injurious stimulus, an autoimmune response, or from a chronic 
low-intensity irritant that persists for an extensive amount of time. A low-intensity 
irritation could cause deleterious changes in tissues, such as fibrosis and necrosis 
1, 14
.  
Oral inflammation can also be described as being localized or generalized/systemic. 
Localized inflammation is generally confined to the site of injury. In contrast, when the 
local control of the inflammation is lost, an exaggerated response with systemic 
activation of the inflammatory response occurs 
9
.  
The etiology of oral inflammatory reactions is multifactorial. Oral inflammation could 
be caused by infections (bacterial, viral, fungal), oral biofilms 
14
, trauma, neoplasia, 
chemotherapy and radiation therapy 
15
, as well as immune-mediated disorders 
16
 and 
systemic conditions 
1
.  
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1.3 DENTURE-RELATED ERYTHEMATOUS STOMATITIS 
1.3.1 Definition, diagnosis and classification  
Denture-related erythematous stomatitis, or denture stomatitis, was first described in the 
medical literature in 1936 by Cahn 
17
 under the name “denture sore mouth”.  
Denture stomatitis is a localized chronic inflammation of the oral mucosa covered by a 
removable prosthesis 
4-6
. It usually affects the palatal mucosa under a complete upper 
prosthesis. The mandibular mucosa is rarely involved as a result of the lesser amount of 
tissue coverage and the continuous contact between the saliva and the lower alveolar 
mucosa 
6, 18
.  
This pathology is often diagnosed clinically by an oral healthcare professional during 
routine examination of denture wearers since denture stomatitis is often asymptomatic 
6, 
19
.  However, symptoms like mucosal bleeding, burning sensation of the palate and 
tongue, tenderness, halitosis, xerostomia, unpleasant taste and dysphagia, could 
occasionally be displayed 
20-22
. 
In research and academic settings, various methods have been used to classify denture-
related erythematous stomatitis. Generally, the classifications are based on three 
essential criteria: the distribution and the stages of the inflammation 
21, 23
, the intensity of 
the inflammation 
24
 and the extent of the inflammation 
25, 26
. 
The first classification of denture stomatitis was introduced in 1958 by Östlund 
27
. He 
distinguished three types based on the distribution of inflammation: I. Localized 
inflammation; II. Diffused erythema limited by the denture margins; III. Granular 
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reaction. Four years later, Newton 
23
 presented a new classification based on Östlund’s. 
This classification, which has been widely used in clinical practice and research, has 
three types: 
Newton Type I: Petechia: pinpoint hyperaemia around the orifices of the ducts of the 
palatal mucous glands;  
Newton Type II: Diffuse hyperaemia: a generalised inflammation of the denture-
bearing area;  
Newton Type III: Inflammatory papillary hyperplasia.  
In 1970, Budtz-Jørgensen and Bertram 
21
 removed the pinpoint hyperaemic lesions of 
Newton’s classification and used the terms: “simple localized inflammation”, “simple 
diffuse inflammation” and “granular inflammation”. A decade later, Bergendal and 
Isacsson 
24
 classified denture stomatitis according to the intensity of the inflammation: 
Grade 0 : Normal pink, pale mucosa; Grade 1 : Slightly erythematous mucosa; Grade 2 : 
Moderately erythematous mucosa; and Grade 3: Pronouncedly erythematous mucosa.   
Schwartz et al. 
26
 added the concept of the extent of the inflammation: 
0 No inflammation 
1 Inflammation of the palate extending up to 20 mm on denture-bearing tissue 
2 Inflammation of the palate extending more than 20 mm on denture-bearing 
tissue 
3 Inflammation covering more than 50 % of the palatal denture-bearing tissue 
Finally in 2003, Barbeau et al. 
25
 modified the Newton classification to provide a more 
accurate evaluation of the extent of the lesion. Newton types II and III were 
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subclassified as A, if inflammation was present in 1 to 2 quadrants, or as B if 
inflammation was present in 3 to 4 quadrants. 
In this master’s research project, in order to capture the difference between petechiae 
and localized inflammation in regard to denture stomatitis treatment, we added two 
subtypes to Newton's Type I denture stomatitis: Type IA: Petechiae around the orifices 
of the ducts of the palatal minor salivary glands; Type IB: Localized area of 
inflammation in denture-bearing area (Figure 1.2). 
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Figure 1.2: Clinical features of denture-related erythematous stomatitis 
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1.3.2 Epidemiology of denture stomatitis  
Denture-related erythematous stomatitis is considered the most prevalent mucosal lesion 
associated with prosthesis use 
4, 5, 28
. In a recent review of the literature by Gendreau and 
Loewy 
29
, the global prevalence of this disease has been reported to be between 15 % 
and 77.5 %. Table 1.1 presents the worldwide prevalence of denture stomatitis in the last 
decade. In Quebec,
 
the prevalence of denture stomatitis in complete denture wearers has 
been reported to be up to 77.5 % 
7, 30
. However, it should be mentioned that these studies 
were mainly university-based and their populations were not representative of Quebec’s 
general population. Although denture stomatitis is generally seen in complete denture 
wearers 
6, 28
, a recent systematic review 
31
 revealed that denture stomatitis has a 
prevalence of 1.1 % to 36 % in partial denture wearers.   
Regarding the relationship between gender and denture stomatitis, many studies found 
that this pathology is more prevalent in women 
17, 32, 33
, whereas some others did not find 
any gender difference 
34, 35
. It could be argued that females may be more susceptible to 
this disease as they are more likely to wear their prosthesis continuously to avoid an 
unesthetic appearance 
36
.  
It has been reported that the prevalence of denture stomatitis increases with age 
34, 37
.  
This could be explained by long-term denture use, inadequate oral hygiene due to the 
lack of dexterity, presence of systemic diseases and medication use, as well as a 
decrease in host immunity in the elderly 
38-42
. Paradoxically, several studies did not 
demonstrate any association between aging and denture stomatitis
 7, 28, 43
.  
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Several risk and predisposing factors have been related to the occurrence of denture 
stomatitis, including continuous and nocturnal wear of the prosthesis 
7
; nutritional 
deficiencies in proteins, vitamins A and B, and iron 
6
; several systemic diseases such as 
diabetes mellitus and immunosuppressive diseases and therapies 
44, 45
; medications such 
as antibiotics, corticosteroids, xerogenic agents and hormone supplementation therapy 
46, 
47
; as well as smoking 
6, 24
.  
Although the literature shows contradictory results in regard to the association between 
these risk factors and denture stomatitis 
6, 7, 35, 48, 49
, there is some evidence that 
highlights the dominant role of nocturnal wear of the prosthesis in this disease 
34, 50, 51
. In 
the cross-sectional study by Barbeau et al. 
25
, participants with extensive palatal 
inflammation were five times more likely to wear their prosthesis at night than healthy 
denture wearers (OR = 5.00; 95 % CI 1.35 to 18.55; p = 0.03). Nocturnal and continuous 
prosthesis wear could reduce the protective effect of saliva, decrease the cleaning effect 
of the tongue, prevent proper oxygenation of the palatal mucosa, and finally, increase 
local trauma to the mucosa. These effects make denture wearers more prone to mucosal 
mechanical and microbiological injuries, and therefore increase the risk of denture 
stomatitis in this population 
7, 30, 51-54
. 
The noticeable variations between studies in regard to the epidemiology of denture 
stomatitis is justified by the inconsistency in methodological aspects of the studies, 
especially in the diagnostic criteria of denture stomatitis, data collection, the choice of 
the study population and its underlying spatial, socio-demographic and lifestyle 
characteristics 
6, 17, 34, 45, 55
.  
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Table 1.1: Denture stomatitis prevalence in the last decade (2003-2013) 
Study/year of 
study/Country 
Study design and 
study population 
Sample size (n) 
and population 
characteristics  
Denture stomatitis 
predisposing factors 
Diagnosis of 
denture 
stomatitis 
Prevalen- 
ce of 
denture 
stomatitis 
(%) 
Espinoza et al. 
56
, 2003, Chile 
 Cross-sectional 
study 
 Random sample of 
individuals from 
public and private  
health systems 
 n = 889 
 62 % F 
 ≥ 65 years old 
Not available Epidemiology 
guide for the 
diagnosis of 
oral mucosal 
diseases 
(WHO) 
34 %  
Barbeau et al. 
25
, 2003, 
Canada 
 
 Cross-sectional 
study 
 Convenience 
samples of 2 
cohorts: 
 Cohort 1: 
university-
based study  
 Cohort 2: 
Individuals 
living or 
working in a 
nursing home 
Cohort 1: 
 n = 47 
 66 % F 
 Mean age 
63.7 ± 11.6 
years 
Cohort 2: 
 n = 21 
 76.2 % F 
 Mean age 
56.3 ± 11.0 
years 
 
 Nocturnal denture 
wear  
 Smoking  
Modified 
version of 
Newton’s 
classification. 
Cohort 1: 
76.6 % 
 
Cohort 2: 
57.1% 
 
Combin-
ed: 70.6 % 
Marchini et al. 
19
, 2004, Brazil 
 Cross-sectional 
university-based 
study 
 Convenience sample 
of completely 
edentate individuals  
 n = 236 
 75 % F 
 Mean age:  
62 ± 12.8 years 
 Poor oral hygiene  
 
Not available 42.4 % 
Shulman et al. 
6
, 2005, United 
States 
 Cross-sectional 
study 
 Edentate individuals 
from the NHANES 
III (1988–1994) 
survey  
 n = 3450 
 42.3 % F 
 Mean age: 
59.2 ± 0.50 
years 
 Vitamin A 
deficiency 
 Nocturnal denture 
wear  
 Smoking ≥15 
cigarettes per day 
Classification 
of Newton 
27.9 % 
Mumcu et al. 
57
, 
2005, Turkey 
 Cross-sectional 
study 
 Random sample of 
completely edentate 
institutionalized 
individuals 
 n = 765, 
 49 % F 
 Mean age: 
35.6 ± 26.6 
years 
Not available Classification 
of Newton 
20.5 %  
Emami et al.  
30
, 
2007, Canada 
 Cross-sectional 
university-based 
study 
 Completely edentate 
individuals 
 n = 40, 
 77.8 % F 
 Mean age: 
64.5 years 
 
 Nocturnal denture 
wear  
 
Classification 
of Newton 
77.5 % 
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Emami et al. 
7
, 
2008 , Canada 
 1-year follow-up of 
a previous RCT. 
 University-based 
study 
 Completely edentate 
individuals 
 n = 173 
 53.8 % F 
 Mean age: 
72.13 ± 4.39 
years 
 
 Nocturnal denture 
wear  
 Type of the 
prosthesis (implant-
supported 
overdenture or 
conventional) 
 
Classification 
of Newton 
63.6 % 
Baran et al. 
58
, 
2009, Turkey 
 Cross-sectional 
university-based 
study 
 Completely edentate 
individuals 
 n = 310 
 49 % F 
 Mean age: 
65.74 ± 2.73 
years 
 
 Poor denture 
hygiene habits 
Classification 
of Newton 
35.8 % 
Divaris et al. 
51
, 
2010, Greece 
 Cross-sectional 
university-based 
study 
 Completely edentate 
individuals 
 n = 873 
 49.45 % F 
 Mean age: 
72.0 ± 5 years 
 Nocturnal denture 
wear  
 
Classification 
of Newton 
6 % 
Ferreira et al. 
5
, 
2010, Brazil 
 Cross-sectional 
study 
 Random sample of 
completely edentate 
individuals from 
nursing homes 
 n = 335 
 73.1 % F 
 ≥ 60 years old  
Not available Epidemiology 
guide for the 
diagnosis of 
oral mucosal 
diseases 
(WHO) 
15.2 % 
Jainkittivong et 
al. 
4
, 2010, 
Thailand 
 Cross-sectional 
university-based 
study 
 Convenience sample 
of  partially or 
completely edentate 
individuals 
 n = 380 
 59.2 % F 
 Mean age 
65.2 ± 9.1 years 
 Not available Epidemiology 
guide for the 
diagnosis of 
oral mucosal 
diseases 
(WHO) 
18.1 % 
Mandali et al.  
37
, 2011, Turkey 
 Cross-sectional 
study 
 Convenience sample 
of completely 
edentate individuals 
from a hospital 
dental clinic 
 
 n = 153 
 50.3 % F 
 Mean age: 
61.8 ± 9.8 years  
 Age 
 Continuous use of 
the dentures 
 
Not available 35.3 % 
Evren et al. 
34
, 
2011, Turkey 
 Cross-sectional 
study 
 Convenience sample 
of institutionalized 
completely edentate 
individuals  
 n = 269 
 55.8 % F 
 ≥ 65 years old 
 Age 
 Education 
 Nocturnal denture 
wear 
 Denture hygiene 
Classification 
of Newton 
44 %  
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Kossioni  
35
,  
2011, Greece 
 Cross-sectional 
university-based 
study 
 Convenience sample 
of completely 
edentate individuals  
 
 n = 106 
 64.2 % F 
 Mean age:  
67.7 ± 9.9 years 
 Continuous denture 
use  
Classification 
of Newton 
39.6 % 
Da Silva et al. 
49
, 2011, Brazil 
 Cross-sectional 
study 
 Convenience sample 
of institutionalized 
of partially of 
completely edentate 
household farmers  
 n = 102 
 82 % F 
 Mean age: 49 
years  
 Female  
 Length of denture 
use 
Classification 
of Newton 
48.2 %  
Mozafari et al. 
59
, 2012, Iran 
 Cross-sectional 
study 
 Convenience sample 
of institutionalized 
elderly individuals 
 n = 202 
 91.1 % F 
 Mean age:  
79.59 ± 8.88 
Not available Not available 54.6 % 
Cueto et al. 
60
, 
2012, Chile 
 Cross-sectional 
study 
 Random sample of 
completely edentate 
individuals from a 
list of patients 
attending medical 
routine consultations 
in a polyclinic. 
 n = 126 
 75 % F 
 Mean age: 
70.2 years 
 Nocturnal denture 
wear  
 poor denture 
hygiene  
 Not well-fitted 
prosthesis 
 
Not available 37.1 % 
Sakar et al. 
54
, 
2013, Turkey 
 Cross-sectional 
study 
 Convenience sample 
of institutionalized 
elderly individuals 
 n = 365 
 66 % F 
 Mean age: 
70.5 ± 13.2 
years 
 
 Age of maxillary 
denture 
 Nocturnal denture 
wear 
 Reduced Vertical 
dimension of 
occlusion 
Classification 
of Newton 
46.3 % 
Pesee et al. 
43
, 
2013, Thailand 
 Cross-sectional 
study 
 Convenience sample 
of partially or 
completely edentate 
individuals from a 
dental clinic located 
in a hospital. 
 
 n = 128 
 67.2 % F 
 Mean age: 
57.11 years 
 Prosthesis quality 
 
Classification 
of Newton 
52.3 % 
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1.3.3 Histopathology and physiopathology of denture stomatitis 
The chronic inflammatory reaction of the palatal mucosa in denture-related 
erythematous stomatitis is characterized by histopathological and physiopathological 
alterations similar to any other inflammatory reaction 
61
.  
The epithelial changes that occur in denture stomatitis include reduced thickness of the 
epithelium, with areas of epithelial hyperplasia or atrophy, as well as accelerated cellular 
turnover of the epithelium 
61-63
. Another important change that was demonstrated in 
several studies was the parakeratinization or absence of keratinization of the surface 
layers of the palatal mucosa 
61-64
. Regarding connective tissue changes, Le Bars et al. 
62, 
65
 compared biopsies of the palatal mucosa of healthy patients wearing complete upper 
dentures with those affected by Type II denture stomatitis. They found a moderate 
inflammation in the connective tissue with the presence of polymorphonuclear 
leucocytes and lymphocytes and the display of thin collagen and a disorganized lamina 
densa. Furthermore, they demonstrated disruptions in the basement membrane.  
Other cytological studies of palatal mucosal smears also showed higher inflammatory 
infiltrates in patients with denture stomatitis than healthy patients 
63, 66
. 
Recently, many research groups highlighted the role of salivary inflammatory mediators 
in denture-related erythematous stomatitis. In a case-control study by Barros et al. 
67
, 
high levels of salivary cytokines such as IL-1β and IL-8 were found in patients with 
Type II and III denture stomatitis. Gasparoto et al. 
68
 assessed patients with Candida-
associated denture stomatitis and found that they had higher salivary levels of IL-4 and 
IL-10.  Pesee et al. 
43
 found no association between the occurrence of denture stomatitis 
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and the salivary levels of IL-6, IL-8, IL-10, IL-17, and TNF-α. However, in this study 
43
, the majority of the study participants (65.7 %) had Type I denture stomatitis.  
With regard to denture stomatitis and the systemic levels of inflammatory markers, the 
literature is still inconclusive. The findings of the longitudinal cohort study by Ajwani et 
al. 
69
 in completely edentate individuals demonstrated higher systemic levels of C-
reactive protein in patients affected by denture stomatitis. In contrast, Barros et al. 
67
 
found that the amount of C-reactive protein was similar in patients with denture 
stomatitis and healthy edentate, suggesting a lack of systemic inflammation associated 
with denture stomatitis. Pietruski et al. 
70
 found that denture wearers had higher serum 
levels of IL-6 and TNF-α, regardless of the presence of denture stomatitis, compared to 
dentate individuals. 
Recently, Matsumoto et al. 
71
 evaluated the cytogenetical damage induced by denture 
stomatitis by means of micronucleus assay in exfoliated cells of the palatal mucosa. The 
findings of this study showed a lack of malignancy risk in denture stomatitis patients. 
However, this chronic inflammation had cytotoxic effects on the cells of the oral mucosa 
by inducing nuclear alterations such as nucleus pyknosis, karyorrhexis and karyolysis 
71
.  
Finally, Kaplan et al. 
72
 compared palatal biopsies of patients with normal mucosa and 
patients with papillary hyperplasia or Type III denture stomatitis. They found no 
evidence of dysplasia in denture stomatitis patients. Similarly, Flanagan and Porter 
73
 
reported no histological premalignant changes in Type III denture stomatitis.  
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1.3.4 Etiology of denture stomatitis 
The etiology of denture-related erythematous stomatitis remains poorly understood and 
controversial 
25, 30
. Three etiologic factors have been reported to play a major role in 
denture stomatitis including fungal infections (particularly Candida) 
32, 74
, denture 
biofilm 
75
 and trauma 
7, 52
.  
Fungal Infection: 
In 1936, Cahn 
17
 was the first to propose Candida infection as a main etiologic factor for 
denture stomatitis. Since then, a relationship between denture stomatitis and fungal 
infection has been widely reported in the literature 
18, 74, 76
. However, several studies did 
not prove any statistically significant association between the presence of denture 
stomatitis, the severity of the inflammation, and the number of Candida Colony-
Forming Units (CFUs) isolated from the prosthesis and the palate of patients affected by 
denture stomatitis 
22, 25, 30, 67, 77
. Furthermore, high recurrence rates of the clinical signs of 
denture stomatitis and recolonization of Candida after the antifungal therapy have been 
widely reported 
78-80
.  
Denture Biofilm: 
Denture biofilm is a surface-attached, dense and complex layer consisting of microbial 
communities and their metabolites, which are embedded in an extracellular 
polysaccharide matrix 
81
. It has been reported that denture biofilm contains 10
11
 
microorganisms per gram 
82
, including aerobic and anaerobic bacteria, yeasts, and 
amoebae 
83
. Poor hygienic habits such as continuous and nocturnal wear of the 
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prosthesis, in addition to inadequate denture cleaning, promote the formation and 
accumulation of denture biofilm. This biofilm harbours a wide array of pathogenic 
microorganisms which produce toxins and metabolic waste. These metabolites in turn 
could initiate the inflammatory process in denture stomatitis 
6, 32, 34, 48, 83, 84
. Furthermore, 
biofilms provide a protective niche for these microorganisms and allow them to become 
resistant to antimicrobials 
83, 85, 86
. 
Trauma: 
The role of trauma in the onset of denture stomatitis was suggested for the first time in 
1929 by Wright 
87
 and since then has been reported in several studies 
20, 21, 52
. Recently, 
many studies have assessed the plausibility of this hypothesis. In the study by Pesee et 
al. 
43
, there was a statistically significantly relationship between the prevalence of 
denture stomatitis and the absence of adequate hygiene, fit, retention and stability of the 
prosthesis. Furthermore, the results of a randomized controlled trial by Emami et al. 
7
 
suggest that a lack of stability of the lower denture can cause trauma to the palatal 
mucosa following the displacement of the upper denture and thus, promote the 
development of denture stomatitis. In fact, in this study, the risk of denture stomatitis 
was 4.5 times greater in patients wearing mandibular conventional dentures than in those 
wearing more stable and less traumatic two-implant overdentures (Adjusted OR = 4.54, 
95 % CI 2.20 to 9.40).  
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1.3.5 Systemic effects of denture stomatitis 
There is overwhelming evidence of the link between oral and general health 
88, 89
. The 
oral mucosa constitutes the lining of ports of entry to several systems of the human 
body. When the mucosal defences are breached, the systemic health could be affected 
90
.  
Although the association between denture stomatitis and systemic disease such as 
diabetes mellitus has been the focus of several studies 
45, 91
, this investigation has always 
been unidirectional, and the direct and indirect impact of denture stomatitis has not been 
examined yet mainly because of the silent nature of this disease. We can hypothesize 
that this disease could affect the general health through two pathways: local infection 
and local inflammation. Evidence regarding the role of local inflammation and infection 
in the development of several diseases supports this hypothesis.  
Denture stomatitis favours the colonization of infectious pathogens which in turn could 
lead to serious disease such as oral candidiasis, bacterial endocarditis and aspiration 
pneumonia, especially in individuals with a compromised immune system, hospitalized 
patients, and elders with cognitive impairments and dementia 
46, 92-98
. 
There is also persuasive scientific evidence on the consequences of chronic 
inflammation 
99, 100
. The evidence of the presence of inflammatory markers such as C-
reactive protein in the saliva and serum of patients affected by denture stomatitis 
suggests that this chronic inflammation may be involved in many seemingly unrelated 
diseases. As we get older, chronic inflammation can have pathological consequences 
throughout the body. As supported by Ajwani et al. 
69
, among the edentulous, chronic 
inflammatory lesions like denture stomatitis are important determinants of inflammatory 
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markers, comparable to periodontal disease in the dentate individuals. This evidence 
shows the need for future and novel studies on this topic. 
1.4 TREATMENT OF DENTURE-RELATED ERYTHEMATOUS STOMATITIS 
The history of the treatment of denture-related erythematous stomatitis demonstrates the 
recognition of this disease as being multifactorial. Therefore, denture stomatitis has not 
received a unique treatment, and a variety of different therapies have been used to treat 
this chronic inflammation 
101-103
. 
The first trace of denture stomatitis treatment dates back to 1929. At that time, the 
etiology of this disease was considered to be trauma and treatments based on the 
reduction of traumatic injuries were introduced. Since 1935, the hypotheses on the role 
of fungal infections in denture stomatitis have convinced most of the clinicians to 
prescribe different kinds of antifungal medications to treat this disease. In 1952, Fisher 
and Rashid 
104
 reported that denture stomatitis is caused by a lack of denture hygiene, 
and recommended improving the oral hygiene of patients. In general, we can classify 
denture stomatitis treatments into two major categories: the conservative methods and 
the use of antifungal medications 
94
.  
1.4.1 The conservative methods  
The conservative approach includes methods that improve the oral and prosthesis 
hygiene and that reduce the trauma to the underlying palatal mucosa. 
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1.4.1. I Oral hygiene measures 
Oral hygiene measures include discontinuous use of the denture, use of mouthwash, 
palatal brushing, laser and photodynamic therapy, prosthesis hygiene, microwave 
disinfection of the prosthesis, and finally the use of phytomedicines.  
1. Discontinuous use of dentures  
As previously mentioned in section 1.3.2, continuous wear of the prosthesis represents a 
risk factor for denture-related erythematous stomatitis 
28, 51
. Several studies show a 
relationship between nocturnal denture wear and the prevalence of denture stomatitis 
6, 
25, 34
, and clinicians usually suggest to their patients to remove their prosthesis at night to 
prevent or improve this disease. A study by Divaris et al. 
51
 demonstrated that removing 
the prostheses during the night was associated with a decreased risk of having denture 
stomatitis (OR = 0.63, 95 % CI 0.44 to 0.90).  
2.  Mouthwash use 
Mouthwashes such as chlorhexidine gluconate (Peridex
™
, Cordosyl
™
) 
105
, chlorine 
dioxide (CloySYS
™
) 
106
, and lawsone methyl ether mouthwash 
107
, have been widely 
used to remove palatal biofilm. In a clinical study by Lal et al. 
105
, 0.12 % chlorhexidine 
gluconate (Peridex
™
) was effective in elimination of C. albicans colonies isolated from 
the denture biofilm and led to a decrease in palatal inflammation. In a randomized 
controlled trial, Koray et al. 
108
 demonstrated that hexetidine mouthrinse was as effective 
as fluconazole capsules in reducing the number of Candida albicans Colony-Forming 
Units (CFUs). Similarly, in a clinical study by Uludamar et al. 
106
, chlorhexidine 
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gluconate and chlorine dioxide mouthwashes decreased the number of C. albicans 
colonies. 
However, the recurrence of denture stomatitis after cessation of the use of these kinds of 
mouthwash has been reported 
105
. In addition, mouthwashes containing chlorhexidine 
could cause side effects such as staining of the teeth and oral mucosa 
109
. 
3. Palatal brushing 
Oral health-care providers often suggest oral and prosthesis hygiene instructions such as 
palatal brushing to complete denture wearers. In a recent observational study 
110
, the 
chance of remission of denture stomatitis was 3.9 times higher in participants who 
brushed their palate (RR = 3.9, CI 1.0 to 15.9, p = 0.04). In addition, an association 
between the lack of palatal brushing and the occurrence of C. albicans was reported (OR 
= 1.8, 95 % CI 1.3 to 2.4, p = 0.03) 
30
. However, there is still a paucity of research on 
this topic; and to our knowledge, no interventional study has examined this mode of oral 
hygiene. 
4. Laser and photodynamic therapy 
Photodynamic therapy (PDT) and Diode laser irradiation have been successfully used in 
the treatment of denture stomatitis 
111-114
. Photodynamic therapy consists of activation of 
a photosensitizing agent by means of oxygen and a light source (Light-Emitting Diode) 
with specific wavelengths. This results in the formation of cytotoxic oxgen molecules 
that damage the cells of the microorganisms 
115
. In a randomized controlled trial, Mima 
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et al. 
113
 evaluated the efficacy of PDT and found this therapy as effective as nystatin in 
the treatment of denture stomatitis. 
The mechanism underlying the diode laser (low-power laser) therapy is not well 
understood. One hypothesis suggests that laser irradiation produces reactive oxygen, 
which reduces the proliferation of the microorganisms 
116
. In a randomized controlled 
trial, Maver-biscanin et al. 
112
 compared the effects of diode laser irradiation with 
antifungal treatment regarding the reduction of Candida CFUs. They found no 
difference between the laser treatment and the antifungal medication regarding the 
remission of denture stomatitis. 
The disadvantages of PDT and diode laser irradiation include the need for special 
equipment and difficulty in implementation. In addition, recurrence of denture stomatitis 
was noted for both treatments 
112, 113
. 
5. Prosthesis hygiene 
Chemical disinfection and mechanical cleaning of the prosthesis can be used to clean the 
dentures. The prostheses can be chemically disinfected by immersing them in cleaning 
solutions containing alkaline peroxide (Polident
®
, Efferdent
®
) 
92, 106, 117
, 0.12 % 
chlorhexidine gluconate (Peridex
™
) 
105
, or sodium hypochlorite 0.05 % (10 ml 
hypochlorite 1 % in 200ml water for 10 minutes) 
118
. Sodium hypochlorite is considered 
an effective, accessible and inexpensive disinfecting agent 
119
, especially when used as a 
Milton
™
 solution (2 % aqueous solution of sodium hypochlorite with 16.5 % salt). This 
solution causes less damage to the dentures when compared to household bleach 
120, 121
.  
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Many studies have been conducted to test the effectiveness of chemical methods in 
denture biofilm removal 
122, 123
. In a randomized crossover trial, Gornitsky et al. 
123
 
assessed the efficacy of three commercial denture cleaners (Denture Brite
®
, Polident
®
 
and Efferdent
®
) in the removal of denture biofilm and in the reduction of the number of 
microorganisms. They did not find any difference between the three brands after 3 
weeks of use. In an in-vitro study, Glass et al. 
92
 found that soaking of the dentures in 
Polident
®
 was more effective in reducing microorganisms’ load than microwaving. 
Some other findings showed that the use of denture cleaners containing chlorine dioxide 
and 0.2 % chlorhexidine gluconate were effective in the elimination of the biofilm 
122
. 
Furthermore, the combination of a denture disinfectant such as chlorhexidine with an 
antifungal treatment was shown to improve the efficacy of the antifungals 
124
. However, 
this combination could increase the resistance of Candida species over time 
125
.  
Several studies compared the efficacy of the chemical and mechanical methods of 
denture cleaning in the treatment of denture stomatitis. Silva-Lovato et al. 
126
 compared 
the cleaning capacity of brushing the prosthesis to soaking in a denture cleaner 
containing sodium lauryl sulphate (NitrAdine
™
). They found that the chemical method 
was more effective in terms of biofilm removal (p < 0.001) and reduction of Candida 
colonies (p < 0.05) than cleaning the prosthesis with a denture brush.  
Paranhos et al. 
117
 conducted a longitudinal study to compare the cleaning capacity of 
alkaline peroxide solution (Bonyplus
®
), mechanical brushing with toothpaste, and the 
combination of both methods. The findings of this study suggest that brushing the 
denture was more effective in biofilm removal than the use of a sodium peroxide 
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soaking solution. However, the most effective method for denture hygiene was the 
combination of mechanical and chemical methods 
117, 127
.  
It should be noted that denture cleansing agents could be corrosive and detrimental to 
the prostheses in long-term use and could have some side effects such as altering the 
taste of denture wearers 
108, 126
. 
6. Microwave disinfection 
Microwaves have been used for disinfection of the prosthesis. The mechanism of action 
of microwaving is not well understood and is attributed to the thermal or non-thermal 
effect 
128
. According to thermal theory, heat generated by the vibration of the molecules 
could result in the disintegration of the microorganisms. The disinfecting effect of 
microwaving could also be the result of non-thermal interactions between the molecules 
of the cell wall of microorganisms and the microwave electromagnetic field 
128-130
.  
Although there is still no definitive guideline for microwave use 
131
, according to the 
literature, the prosthesis should be disinfected once a week by immersion in a 600 ml 
container with 200 ml of water, and irradiated at 650 W for 3 minutes 
132, 133
.  
According to several studies, microwaving is as efficient as other alternatives such as 
sodium hypochlorite soaking 
121
, and miconazole and nystatin medications 
80, 128, 132
, in 
the treatment of denture stomatitis. This method is simple and user-friendly, especially 
for the elderly with decreased dexterity 
131
. However, in most of these studies, high 
recurrence rates of denture stomatitis after cessation of the microwaving were 
demonstrated 
80, 128
. In addition, microwave disinfection could lead to the shrinkage of 
the denture bases 
134
 or a decrease in the hardness of the denture teeth 
135
. 
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7. Phytomedicines 
Lately, there has been a tendency toward the use of herbal and natural remedies 
(phytomedicines). The recent narrative review by Casaroto and Lara 
136
, in addition to 
several studies 
78, 137, 138
, reported that phytomedicines are effective in the treatment of 
denture stomatitis.  
In a recent randomized double-blind clinical trial, Bakhshi et al. 
137
 compared the effect 
of nystatin and garlic aqueous extract on denture stomatitis. Both treatments produced a 
statistically significant decrease in the extent of the erythema caused by denture 
stomatitis. Although a faster effect was noted with the use of nystatin, the garlic extract 
had fewer side effects than the antifungal. In another randomized controlled trial, the 
efficacy of the essential oil of the Z. multiflora herb was compared to 2 % miconazole 
gel 
78
. Z. multiflora exhibits antimicrobial activity and can inhibit the activity of 
inflammatory mediators 
139
, and proved to be as effective as the miconazole gel in the 
treatment of denture stomatitis.  
The extract of Punica granatum Linné (pomegranate) 
140
 and propolis gel 
138, 141
 (a 
resinous substance collected by bees from plants), were also as effective as miconazole 
gel in the treatment of denture stomatitis. Other natural substances that were examined 
and were effective in the treatment of denture stomatitis include vinegar 
142
, Melaleuca 
alternifolia extracts (tea tree oil) 
143
, Satureja hortensis essential oil 
144
 and Ricinus 
communis 
145
. Nonetheless, it should be noted that phytomedicines can have side effects 
such as bad taste, in addition to recurrence and relapse after cessation of their use 
78, 137
. 
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1.4.1. II Prosthodontic measures 
Several prosthodontic procedures with the aim of improving the fit and the stability of 
the prosthesis can be performed in the cycle of treatments of denture stomatitis. These 
include the use of tissue conditioners, prosthesis adjustments, and the renewal of the 
prosthesis 
38
.  
Tissue conditioners are used to manage ill-fitting dentures and inflamed tissue under the 
prostheses. They have a cushioning effect that improves distribution of the occlusal 
forces and decreases trauma to the underlying tissues 
146
. Tissue conditioners have been 
shown to be successful in reducing palatal inflammation associated with denture 
stomatitis 
147, 148
. However, they were not effective in the treatment of the candidiasis 
associated with this disease 
102
. Furthermore, the resilient quality of tissue conditioners 
decreases with time and they become hard, stained and porous. This time-related 
deterioration of the material contributes to the microorganisms’ colonization 149, 150.  
A number of studies examined the efficacy of incorporating antifungals in denture lining 
materials 
143, 150-152
. Geerts et al. 
150
 evaluated the benefit of adding an antifungal in a 
short-term denture liner. Their findings showed that antifungals inhibit the colonization 
of Candida species in the relining material.  
Hard autopolymerising reline materials have also been examined in the treatment of 
denture stomatitis. These hard liners are long lasting, produce a low polymerising 
exothermic reaction and can be used directly in the mouth. In a randomized controlled 
trial by Marin Zuluaga et al. 
153
, treatments with hard and soft tissue conditioners were 
found to be equally effective in the management of denture stomatitis. However, the 
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time needed for remission of inflammation was longer for the soft tissue conditioners 
compared to the harder one.   
In a one-group pre-test/post-test study, Pires et al. 
18
 evaluated the effect of new well-
fitted complete dentures on denture stomatitis. They found a 30 % decrease in the 
frequency of this disease. However, there was no change in the number of Candida 
colonies. In accordance with several studies 
103, 154
, Arikan et al. 
124
 found that the 
making a new prosthesis for patients with denture stomatitis will improve the localized 
inflammation but will have no effect on generalized inflammation and colonization of 
Candida.  
1.4.2 Antifungal medications  
Antifungal medications are used to eliminate different fungal species, particularly 
Candida species. The antifungals used in the treatment of denture stomatitis can be 
applied topically or used systemically. Topical antifungals include the polyenes (nystatin 
or amphotericin B) used as lozenges or suspensions and the imidazoles derivatives (such 
as clotrimazole and miconazole), used as gel or lacquers. Ketoconazole and the triazole 
derivatives (fluconazole and itraconazole) could be prescribed as tablets or capsules for 
systemic use 
21
. Recently, other triazole antifungal agents with broader spectrum activity 
like voriconazole, ravuconazole, and posaconazole have been used to treat oral 
candidiasis associated with denture stomatitis, especially in immunocompromised 
patients 
155, 156
.  
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Nystatin is the most widely used antifungal in the treatment of oral candidiasis and 
denture stomatitis. Dentures can be soaked in a solution of nystatin (100,000 U/ml). 
Nystatin cream (100,000 U/g) could also be applied to the inner surface of the 
prosthesis. Treatment should continue for a minimum of 4 weeks along with meticulous 
oral hygiene maintenance 
157
. 
The use of antifungal medications to treat denture stomatitis has been studied by several 
research groups 
24, 101, 158
. In a randomized controlled trial by Cross et al. 
79
, itraconazole 
cyclodextrin solution and itraconazole capsules were found to be similar in terms of 
reduction of clinical signs of denture stomatitis and reducing the colonization of the 
yeast. However, recolonization of Candida species was seen at 6-month follow-up. 
Similar results were found in studies comparing the systemic and topical application of 
antifungals such as ketoconazole, fluconazole and amphotericin 
101, 159
.   
Some attempts have been conducted to produce a topical antifungal with long-lasting 
effect to avoid the side effects of systemic antifungals. For example, miconazole has 
been incorporated in lacquer agents. This treatment proved to have a short-term effect 
and recolonization of Candida was observed after treatment 
160, 161
.   
As previously mentioned in section 1.4.1, several studies 
26, 78, 108, 113, 128
 compared 
antifungal treatments with different conservative methods. No significant differences 
between the antifungal and the conservative methods were found.  
Antifungal medications have multiple disadvantages such as side effects, the emergence 
of resistance, and recurrence.  
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The excessive use of antifungals may produce some side effects, such as bitter taste, 
nausea, gastrointestinal disturbance, hypersensitivity, renal and liver toxicity, and 
interaction with other medicines 
46, 47, 50
. Side effects are especially seen with the use of 
systemic antifungals 
79, 101, 137, 162
. 
Furthermore, resistance, which is defined as non-resolution of an infection despite the 
use of an antimicrobial agent, have been demonstrated with antifungal medications 
156, 
163
. High recurrence rates of denture stomatitis have also been reported after cessation of 
the antifungal treatment 
32, 78, 101, 150, 164
. The emergence of resistance may explain this 
extensive recurrence of denture stomatitis 
86, 125, 165, 166
. 
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CHAPTER II 
METHODOLOGY 
2.1 PROBLEMATIC, HYPOTHESIS, OBJECTIVES 
Denture stomatitis is the most prevalent oral disease in denture wearers
 35, 60
. The 
treatment of this disease consists of two different approaches: the use of antifungal 
medications and the conservative approach 
94
.  
Antifungal therapy is the main choice of oral healthcare professionals for the treatment 
of this disease, based on some evidence that Candida is the main etiological factor in the 
onset of denture stomatitis. However, a direct cause-and-effect relationship has never 
been shown, and high recurrence rates of denture stomatitis clinical signs and 
recolonization of Candida have been reported after cessation of the antifungal treatment 
78-80
.  
Recent research on the etiology of denture stomatitis suggests that treatments based on 
the reduction of the inflammation are effective in the management of this disease 
7, 25
. In 
this regard, some new findings suggest palatal brushing as a curative method 
110
. 
However, to our knowledge, there is still no interventional study that has evaluated the 
efficacy of such an alternative approach.  
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2.1.1 Objectives 
The objectives of this master’s research project were: 
1. Primary objective: To assess the efficacy of palatal brushing in the treatment of 
denture stomatitis.  
2. Secondary objectives:  
a) To assess the efficacy of palatal brushing in controlling the colonization 
of Candida species. 
b) To standardize the study procedures and to produce preliminary data for a 
phase-II clinical trial. 
2.1.2 Hypotheses 
We tested the following null hypotheses: 
1. There is no difference in the extent of palatal inflammation in individuals with 
denture stomatitis before and 3 months after palatal brushing. 
2. There is no difference in the number of Colony-Forming Units (CFUs) of 
Candida isolated from the palate and denture of patients with denture stomatitis 
before and 3 months after palatal brushing. 
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2.2 RESEARCH METHODOLOGY  
2.2.1 Study design  
This study was a phase-I clinical trial with a one-group pre-test/post-test design. It has 
been registered in clinicaltrials.gov and received the identification number 
NCT01643876. The project was conducted at two Faculties of Dentistry of the 
Université de Montréal in Canada and the University of São Paulo (Ribeirão Preto) in 
Brazil.  
2.2.2 Study participants and inclusion criteria 
Study participants were recruited from the general population of the area of 
Metropolitan Montreal and Ribeirão Preto via advertisements in local newspapers, 
through flyers placed within dental clinics of the two dental schools, or by clinicians 
during clinical examination at diagnostic clinics of these faculties.  
All potential participants were informed about the study, and those who were willing to 
participate in the study were invited to a screening clinical session. During this session, 
the master’s students explained all aspects of the study, and examined candidates for 
suitability for inclusion in the study.  
Candidates were considered for inclusion in this study if they: 
1) were 18 years old or older;  
2) were wearing a complete upper denture;  
3) had a clinical diagnosis of denture stomatitis; 
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4) had the ability to understand and sign an informed consent form.  
Candidates were excluded from the study if they: 
1) had any conditions known to promote Candida carriage such as uncontrolled 
diabetes, anemia, xerostomia or immunosupression; 
2) received a treatment with an antibiotic, an antifungal or corticosteroids in the last 
four weeks prior to the study or were being treated with chemotherapy or 
radiotherapy;  
3) included palatal brushing in their routine oral hygiene; 
4) were planning to change their existing prosthesis during the trial. 
Each individual meeting the eligibility criteria were invited to read and sign the consent 
form (Appendix I). They were given an opportunity to ask questions and to take the 
research consent form home for further consideration.  
Finally, forty-eight consecutive participants (men = 16, women = 32) from the two study 
centers (Canada, n = 22; Brazil, n = 26) participated in the clinical trial.  
2.2.3 Experimental procedure 
The experimental procedure (intervention) consisted in brushing the palate with a soft-
bristle manual brush (Oral-B
®
 CrossAction
®
 Pro-Health
™
) after each meal and before 
sleeping, for a period of 3 months.  
In order to standardize the experimental technique, the participants were asked to keep 
to their usual oral and denture hygiene routine during the trial. A cast model was used to 
show the participants how to brush the palate. The study participants also received a 
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written instruction sheet (Appendix V) to remind them of the study’s experimental 
procedure. 
2.2.4 Data collection and measurement instruments 
The data collection was conducted at the postgraduate prosthodontic clinics of the 
Faculties of Dentistry of the Université de Montréal and the University of São Paulo at 
baseline (T0), 1 month (T1), and 3 months (T2) of the intervention, during the period 
extending from May 2012 to January 2013.  
One master’s student in each center (MK and MB) was responsible for the data 
collection. Data were collected by means of a self-administered questionnaire (Appendix 
II), a clinical examination (Appendix III) and a microbiological investigation (Appendix 
IV). All procedures were standardized between the two centers during research team 
meetings before data collection.  
2.2.4. I Clinical investigation 
In each center, the diagnosis of denture stomatitis was conducted by three trained, 
calibrated dentists (interobserver reliability 0.6 to 0.84) using a front-surface mirror and 
probe (XP23/QW, HuFreidy).   
Furthermore, the photographs of palate were taken with a Nikon D90 camera (105mm 
f/2.8 D; macro flash SB-21). These photographs were used to obtain a diagnostic 
consensus from research team members during a workshop held at the faculty of 
Dentistry of the Université de Montréal from November 19
th
 to December 7
th
, 2012.  
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Denture stomatitis was diagnosed according to the area and severity of inflammation 
indices 
26
 and a modified classification of Newton 
23
, as detailed below:   
I. Inflammation area index:  
0: No inflammation  
1: Inflammation of the palate extending up to 25 % of the palatal denture-bearing 
tissue  
2: Inflammation of the palate extending between 25 % and 50 % of the palatal 
denture-bearing tissue 
3: Inflammation covering more than 50 % of the palatal denture-bearing tissue. 
 
II. Inflammation severity index:  
0: Normal tissue  
1: Mild inflammation (slight redness, no swelling or edema) 
2: Moderate inflammation (redness with some edema)  
3: Severe inflammation (acutely inflamed redness, edema) 
 
A score between 0 and 6 for total inflammation was then given, which equals the 
area + intensity of inflammation 
26
. 
 
III. The modified classification of Newton: 
0: Healthy mucosa 
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Type IA: Petechiae in a normal palatal tissue, which are usually found around 
the orifices of the ducts of the palatal mucous glands  
Type IB: Localized area of inflammation of the denture-bearing area 
Type II: Generalized area of inflammation of the denture-bearing area 
Type III: Hyperplasic palatal surface with inflammation of the denture-bearing 
area. 
The other assessed variables included denture cleanliness, which was evaluated by the 
modified Hoad-Reddick classification 
167
, as clean (without any soft/hard debris or stain) 
or dirty (with soft and hard debris or stain after washing under water).  
The upper prostheses were also evaluated regarding their stability and retention. The 
stability was evaluated by determining the movement of the prosthesis over the 
supporting tissues and its resistance to rotation. The presence or absence of a noticeable 
rocking motion was also noted 
168, 169
. The retention was evaluated by asking the 
participant to touch the vermillion border of their upper lip with their tongue and by 
opening their mouth to the maximum. If the denture dropped, it was considered non-
retentive. The upper prosthesis was grasped by the thumb and index finger and a 
downward force was applied. The absence or presence of adequate resistance to 
dislodgment was noted 
168, 169
. 
Other explanatory variables included the clinical signs of parafunctional habits, salivary 
flow, and the resorption and tissue resilience of the upper residual ridge 
170-173
, in 
addition to the vertical dimension of occlusion 
168, 169
. 
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Information about socio-demographic variables (age, sex, education, medical and 
dental histories, medication profiles), years of edentulism and age of the dentures, 
hygienic habits (cleaning frequency, nocturnal wear, mouthwash use) and smoking, were 
obtained from a validated questionnaire 
30
.  
The level of the reported oral hygiene was estimated through questions with categorized 
answers (How many times per day do you clean your dentures? How do you clean your 
dentures?). The answers were binary summarized as cleaning of the dentures less than 
two times/day or 2 times and more/day; and brushing the dentures or washing without 
brushing.  
A 100 mm visual analogue scale (VAS), with anchor words of “not at all satisfied” and 
“extremely satisfied” 7, was also used to assess the general satisfaction with oral 
condition. Furthermore, symptoms and side effects of palatal brushing, if present, were 
reassessed after 1 and 3 months of the intervention. 
2.2.4. II Microbiological investigation 
In order to evaluate the colonization of Candida species, microbiological investigations 
on the upper denture and palatal plaques were conducted. With this aim, the sonication 
technique 
121, 174
 and swabs were used to collect the upper denture biofilm and palatal 
biofilm, respectively.  
 In brief, the upper prosthesis was rinsed under tap water and placed in a Ziploc™ 
plastic bag with 30 ml of sterile saline water (0.85 % sodium chloride). The first bag was 
then put in a second bag and sonicated for 5 minutes at room temperature in an 
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ultrasonic bath containing distilled water (Cole Parmer 08890-21, 50/60 Hz, 1,3 Amp). 
The recovered plaque (sonicate) was transferred to a 50 ml sterile tube. 
A sample of palatal plaque from 1 cm² of the central surface of the palate was collected 
by the use of a sterile swab. The swab was then placed in a sterile tube with 5ml saline 
and sonicated for 2 minutes. Both denture and palatal plaque sonicates were placed on 
ice until the microbiological examination. 
Sonicates were mixed by vortex for one minute and diluted 10-fold serially with saline 
(dilution factors: 10
0
, 10
-1
 and 10
-2
). A volume of 100 μL of each dilution was spread-
plated in duplicate on Sabouraud-Dextrose 4 % Agar (Difco™, Becton, Dickinson and 
Company, USA). All cultures were incubated at 37
o 
C for 48 hours. Colony-Forming 
Units (CFUs) were counted and expressed as a number of CFUs/ml, after correction for 
volume and dilution factor.  
When a growth was observed, an imprint of colonies was obtained onto a sterile filter 
paper which was transferred on a Candida selective growth medium (CHROMagar 
Candida, Paris, France) and incubated under the same conditions. This chromogenic 
selective medium allows identification of the different Candida species 
175
.  
2.2.5 Outcome and explanatory variables 
The remission of denture stomatitis was considered as a primary outcome variable. The 
secondary outcome variable was the diminution of the Candida CFUs. The explanatory 
variables included socio-demographic characteristics and well-known denture stomatitis 
risk factors 
30
. 
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2.2.6 Statistical analysis 
Assuming that the minimal practically important pre/post difference in the mean change 
score is 20 % and the standard deviation of the distribution of the change in score is 0.8 
(based on estimates from a previous study 
110
), a sample size of 44 participants is 
required to ensure a power of 90 % of rejecting the null hypothesis if it is indeed false. 
An additional number of individuals were considered to prevent the effect of potential 
10 % drop-outs on the study results. 
Inter-rater agreement for the diagnosis of denture stomatitis was evaluated by using 
Cohen’s kappa (k) 176, with k value > 0.75 representing excellent agreement, 0.4–0.75 
fair to good agreement and < 0.40 poor agreement.  
In order to obtain frequency counts, percentages and univariate means, and to test for 
normality, the data was first subjected to descriptive statistical tests. Non-parametrical 
analyses were applied because of the deviation from a normal distribution.  
Between-center differences in regard to baseline characteristics of the participants and 
treatment effects were analyzed by means of the Fisher's exact test, two-sample t-test 
and the Mann–Whitney U test.  
The Wilcoxon Signed Rank Test was used to analyze the change in the classifications 
level, in the total score, and in the number of Candida colonies between T0 and T2. 
McNemar’s test was used to determine if there were differences in the participants’ 
reported symptoms between T0 and T2. 
 The Budtz-Jorgensen 
177
 index was used to categorize the clinical effects of treatment: 
 Large effect: inflammation resolved 
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 Moderate effect: inflammation reduced 
 No effect: no change in inflammation 
 Negative effect: increased inflammation 
The effect size r was calculated from the Z obtained from the Wilcoxon Signed Rank 
Test (r = Z/√N, where N is the number of observations over the two time points) and 
was defined as 0.1 = small effect, 0.3 = medium effect and 0.5 = large effect 
178
.  
Differences were considered statistically significant at p ≤ 0.05. All statistical analyses 
were performed by using SPSS version 20 (SPSS Inc., Chicago, IL, USA) and SAS 9.1 
software. 
2.2.7 Ethical considerations 
The ethical approval for this master’s research project was obtained from the Université 
de Montréal Research Ethics Board (CERES, certificate number 12-019-CERES-D) and 
the Institutional Review Board of the Ribeirão Preto Dental School (certificate number 
00625912.6000.5419).  
2.3 STUDY RELEVANCE  
To our knowledge, this study is the first clinical trial on the effect of palatal brushing on 
denture stomatitis. The results of this study will provide clinicians with scientific 
evidence on a simple, conservative, cost/effective therapeutic and preventive approach 
that will contribute to the improvement of oral health in edentate individuals wearing 
complete dentures. The findings of this clinical trial will also assist clinicians in their 
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decision-making in regard to the treatment of denture stomatitis and will avoid the 
over-prescription of antifungal medications. 
Finally, this phase-I clinical trial will allow the elaboration of a randomized clinical trial 
on the efficacy of palatal brushing in comparison with the use of antifungal medications. 
2.4 CANDIDATE’S ROLE IN THE PROJECT 
During this master’s project, the candidate has fulfilled several roles. First of all, she 
helped in the research protocol development. She was responsible for the recruitment of 
the study participants, data collection and data analyses. She was in charge of the 
coordination of the study between the Canadian and the Brazilian centers. She also 
participated actively in the knowledge-transfer phase of this research project. 
2.5 KNOWLEDGE TRANSFER 
The candidate presented the results of this research project during several scientific 
meetings and conferences: 
1) Oral presentation: “Séminaires de recherche en médecine dentaire” (SAB6604-
A11) at the Université de Montréal;  
2)  Poster presentation :  
i. Kabawat M, De Souza RF, De Koninck L, Barbeau J, Rompré P, Emami E. 
Phase-I clinical trial on the effect of palatal brushing on denture stomatitis. 
Journées Dentaires Internationales du Québec (JDIQ), Montreal, Canada, 
May 24
th
 to 28
th
 2013. 
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ii. Kabawat M, De Souza RF, De Koninck L, Barbeau J, Rompré P, Emami 
E. Phase-I clinical trial on the effect of palatal brushing on denture 
stomatitis. Canadian dental research student workshop, Ontario, Canada, 
June 10
th
 to 11
th
 2013. 
The candidate was also co-author of 3 articles on the topics related to the master’s 
project: 
1) Emami E, De Souza RF, Kabawat M, Feine JS. The impact of edentulism on oral 
and general health. International Journal of Dentistry; 2013:498305. doi: 
10.1155/2013/498305. Epub 2013 May 8. 
2) Emami E, Kabawat M, De Koninck L, Gauthier G, de Grandmont P, Barbeau J. 
La stomatite prothétique: nouvelle perspective. Journal de l’Ordre des Dentistes 
du Québec 2013; 50(4):7-12.  
3) Emami E, Kabawat M, Rompré P, Feine JS. Linking evidence to treatment for 
denture stomatitis: a meta-analysis. Journal of Dentistry 2013; Submitted. 
The article included in chapter III of this master’s thesis was also submitted for 
publication in The International Journal of Prosthodontics. 
Finally, the candidate will present the results of this study during The International 
Association for Dental Research (IADR) General Session in 2014. 
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Phase-I clinical trial on the effect of palatal brushing on denture 
stomatitis 
ABSTRACT 
Objectives: To assess the efficacy of palatal brushing in the treatment of denture 
stomatitis. 
Methods: After screening 143 individuals with a potential diagnosis of denture 
stomatitis, 48 (mean age: 66.0 ± 11.2 years) were enrolled in a phase-I two-center 
clinical trial with one-group pre-test/post-test design. The intervention of interest was 
manual palatal brushing after each meal and before bedtime. Clinical and 
microbiological examinations were performed at baseline, 1 month and 3 months post-
intervention. Additional data were obtained by the use of a validated questionnaire. The 
primary and secondary outcomes were the remission of denture stomatitis and the 
diminution of Candida Colony-Forming Units (CFUs), respectively. Descriptive and 
non-parametric statistical tests were conducted to analyze the data. 
Results: At 3-month follow-up, denture stomatitis was completely cured in 10.4 % of 
the study participants, and 70.8 % of denture wearers showed improvement in the 
clinical signs of denture stomatitis. There was a significant reduction in the area and 
severity of the palatal inflammation at 3-month follow-up (p < 0.0001). The effect size 
ranged from medium to large (0.34 to 0.54), depending on the classification used for the 
diagnosis of denture stomatitis. Furthermore, a significant reduction in the number of 
Candida CFUs isolated from the palatal mucosa and dentures (p ≤ 0.05) was observed. 
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Conclusion: The results of this study suggest that palatal brushing is effective in the 
treatment of denture stomatitis. 
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INTRODUCTION 
Denture stomatitis is a chronic inflammation of the oral mucosa covered by a removable 
denture. It is considered the most common mucosal lesion associated with denture use 
1, 
2
, affecting one in every three complete denture wearers 
3
. Several risk factors have been 
reported to be associated with denture stomatitis, including trauma 
4
, denture biofilm 
5
, 
bacterial and fungal infections, particularly by Candida albicans 
6
. However, the 
etiology of this pathological condition remains multifactorial and controversial 
7, 8
. A 
variety of treatments reflecting the multifactorial etiology of denture stomatitis have 
been used in dental practice. These treatments can be basically classified into two 
categories: the conservative approach and the use of antifungal medications. 
Nowadays, antifungal medications are prescribed routinely by oral healthcare 
professionals for the treatment of denture stomatitis, based on the hypothesis that an 
infection by Candida is the main etiological factor of this disease 
9-11
. However, a 
convincing cause-and-effect relationship between the presence of denture stomatitis and 
Candida has never been demonstrated 
7, 8, 12
. Furthermore, high recurrence rates of 
denture stomatitis and recolonization of Candida have been reported after the cessation 
of antifungal treatment 
9, 13, 14
.  
Recent research findings suggest that trauma from unstable dentures induces a local 
inflammation and creates an environment favourable to the proliferation of 
microorganisms 
4
. Consecutively, Candida colonization becomes a secondary stage in the 
pathogenesis of denture stomatitis 
7, 15
. This suggests that treatments that enable the 
remission of inflammation could be effective in the treatment of this disease.  
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Palatal brushing is a simple procedure that could reduce the extent of inflammation by 
different mechanisms such as the removal of denture plaque and the stimulation of the 
mucosal circulation and salivary flow. However, no previous clinical trial has evaluated 
palatal brushing as a treatment modality for denture stomatitis. 
Therefore, the objective of this study was to assess the efficacy of palatal brushing in the 
treatment of denture stomatitis. We tested the null hypotheses that, in individuals with 
denture stomatitis, there are no difference in the extent of palatal inflammation and in the 
number of Candida Colony-Forming Units (CFUs), before and 3 months after palatal 
brushing. 
MATERIALS AND METHODS 
Study Design and Study Participants 
A one-group pre-test/post-test research design was used to conduct a two-center phase-I 
clinical trial (clinicaltrials.gov ID # NCT01643876), at two Faculties of Dentistry of the 
Université de Montréal (Canada) and the University of São Paulo (Ribeirão Preto, 
Brazil). Participants were recruited from the general population of the area of 
Metropolitan Montreal and Ribeirão Preto via advertisements in local newspapers, 
through flyers placed within dental clinics of the two dental schools, or by clinicians 
during examination at diagnostic clinics of these faculties.  
The inclusion criteria of the study were: a) being 18 years old or older, b) wearing a 
complete upper denture, and c) having a clinical diagnosis of denture stomatitis. Patients 
were excluded if they: a) had any conditions known to promote Candida carriage such 
as uncontrolled diabetes, anemia, xerostomia or immunosuppression; b) received a 
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treatment with an antibiotic, an antifungal or a corticosteroid or if they were under 
chemotherapy or radiotherapy in the last four weeks prior to the enrollment in the study; 
c) used palatal brushing as a routine oral hygiene procedure; and d) if they changed their 
existing prosthesis during the trial. The study was approved by the Université de 
Montréal Research Ethics Board and the Institutional Review Board of the Ribeirão 
Preto Dental School. Written informed consent was obtained from the participants prior 
to their participation in the clinical trial.  
Experimental Procedures 
Data collection was conducted at baseline (T0), 1-month (T1) and 3-month (T2) after the 
intervention, by means of a self-administered questionnaire, clinical examination and 
microbiological investigation. 
1. Intervention 
The intervention consisted of brushing the palate with a soft-bristle manual toothbrush 
(Oral-B
®
 CrossAction
®
 Pro-Health
™
, Procter & Gamble, Iowa, IA, USA) after each 
meal and before sleeping, for a period of 3 months. Participants were instructed to brush 
their palate using horizontal, vertical and vibration movements. They were also asked to 
keep their usual oral and denture hygiene habits during the trial.  
2. Clinical investigation  
Denture stomatitis was assessed according to the modified Newton classification 
16
, and 
by means of the area and severity of the inflammation indices 
17
 (Table 3.1).   
The clinical assessment was conducted by two trained, calibrated dentists using a front 
surface mirror and probe (XP23/QW, Hu-Friedy, Chicago, IL, USA). Photographs of 
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palate were taken with a Nikon D90 camera (105mm f/2.8 D; macro flash SB-21, 
Nikon Co., Tokyo, Japan). These photographs were used to obtain a diagnostic 
consensus from research team members. A good to excellent interobserver reliability 
was obtained (κ = 0.6 to 0.84). 
3. Microbiological investigation 
Collection of the upper denture biofilm was carried out by the sonication technique, 
according the protocol described by Emami et al. 
8
. A sample of palatal biofilm was also 
collected by the use of a sterile swab 
18
, placed in a tube with 5ml saline and sonicated 
for 2 minutes. Both denture and palatal biofilm sonicates were subsequently mixed by 
vortex for one minute and diluted 10 fold serially with saline (dilution factors: 10
0
, 10
-1
 
and 10
-2). A volume of 100 μL of each dilution was spread-plated in duplicate on 
Sabouraud-Dextrose 4 % Agar (Difco™, Becton Dickinson Co., Detroit, MI, USA). All 
cultures were incubated at 37
o
C for 48 hours. Colony-Forming Units (CFUs) were 
counted and expressed as a number of CFUs/ml, after correction for volume and dilution 
factor. When a growth was observed, an imprint of colonies was obtained onto a sterile 
filter paper, which was transferred on a Candida selective growth medium 
(CHROMagar™, Candida, Paris, France) and incubated under the same conditions. This 
chromogenic selective medium allows identification of the Candida species 
19
 
4. Outcome measures and explanatory variables 
The remission of denture stomatitis was considered as a primary outcome variable, and 
it was defined as decrease in the level of the modified Newton classification, decrease in 
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the area and the severity of the inflammation, as well as decrease in the total score of 
inflammation (inflammation area + severity) 
17
. 
The Budtz-Jorgensen index 
20
 was used to evaluate the magnitude of the treatment effect 
(based on the total score of inflammation): Large effect: inflammation resolved; 
Moderate effect: inflammation reduced; No effect: no change in inflammation; Negative 
effect: increased inflammation.  
The secondary outcome variable was the reduction in the number of CFUs of Candida.  
Explanatory variables included sociodemographic variables (age, sex, education, 
medical and dental histories, and medication profiles), years of edentulism and age of 
the upper dentures, hygienic habits (cleaning frequency, nocturnal wear, mouthwash 
use) as well as smoking. This information was obtained from a self-administrated 
questionnaire 
8
. General satisfaction with oral condition was assessed by a 100 mm 
visual analogue scale (VAS) 
4
. Other independent variables included denture cleanliness, 
evaluated by means of the modified Hoad-Reddick classification 
8, 21
, and the stability 
and retention of upper prostheses 
22, 23
. Denture stability was evaluated by determining 
the movement of the prosthesis over the supporting tissues and its resistance to rotational 
movement. The upper prosthesis was grasped in the premolar region with the thumb and 
index finger and a rotational force was applied in the occlusal plane. A displacement of 
5 mm or more was considered as prosthesis instability. The prosthesis was considered 
retentive if there was a resistance to downward force when grasping the prosthesis by 
the thumb and index finger 
22, 23
.  
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The wear of the denture teeth, the salivary flow, the resorption and the resilience of the 
upper residual ridge, as well as the vertical dimension of occlusion 
22-27
, were also 
evaluated.  
Furthermore, symptoms of denture stomatitis and side effects of palatal brushing, if any, 
were documented. 
Statistical Analyses 
Assuming that the minimal practically important pre/post difference in the mean change 
score is 20 percent and the standard deviation of the distribution of the change in score is 
0.8 
28
, a sample size of 44 participants is required to ensure a power of 90 % of rejecting 
the null hypothesis if it is indeed false. An additional number of individuals were 
considered to address potential 10 % drop-outs on the study results. 
Cohen’s kappa (κ) coefficient 29 was used to evaluate the inter-rater agreement for the 
diagnosis of denture stomatitis, with κ value > 0.75 representing excellent agreement, 
0.4–0.75 fair to good agreement and < 0.40 poor agreement. 
In order to obtain frequency counts, percentages, univariate means and to test for 
normality, the data was first subject to descriptive statistical tests. Non-parametrical tests 
were applied because of the non-normal distribution of data.  
Between-center differences in regard to baseline characteristics of the participants and 
treatment effects were analyzed by means of the Fisher's exact test, two-sample t-test 
and the Mann–Whitney U test.  
The Wilcoxon Signed Rank test was used to compare the level of the modified Newton 
classification, the area and the severity of the inflammation, the total score of 
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inflammation as well as the number of Candida colonies between baseline and follow-
ups. McNemar’s test was used to compare nominal data on patient-reported symptoms at 
baseline and follow-ups. The level of significance was set at 0.05. 
The Fisher's exact test and two-sample t-test were used to examine the significance of 
association between the explanatory variables and the treatment effect. Logistic regression 
was not conducted because of non-significant association (p > 0.10) in bivariate analyses.  
Statistical analyses were performed using SPSS version 20 (SPSS Inc., Chicago, IL, USA) 
and SAS 9.1 software (SAS Institute, Cary, NC, USA). 
RESULTS 
From a total of 143 individuals who participated in the screening sessions, 48 patients (16 
men, 32 women; mean age: 66.0 ± 11.2 years) were enrolled in this study. Figure 3.1 
illustrates the flow of participants throughout the study, indicating that there were no 
dropouts. Tables 3.2 and 3.3 present the socio-demographic characteristics of the 
participants and their profiles according to denture stomatitis risk factors at baseline, by 
study center. 
The mean year of edentulism in the maxillary arch was 37.2 ± 14.7 years and the mean 
age of the current upper prostheses was 15.3 ± 13.7 years. Signs of wear facets on 
denture teeth were observed in 77.1 % of the participants. The majority of the patients 
brushed their prostheses with toothpaste (79.2 %), and 31.3 % used a denture-cleaning 
agent. However, only the Canadian center participants used the latter. Twenty percent of 
the participants had previously received denture hygiene instructions. Only one 
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participant used denture adhesive on his upper denture. At baseline, the most reported 
symptoms of denture stomatitis were halitosis (52.1 %) and a dry mouth sensation (66.7 
%). The salivary flow was adequate in 83.3 % of the participants, and 91.7 % had a well-
rounded ridge with sufficient height and width (Class III resorption 
27
). Finally, 39.6 % 
of the patients had resilient tissue covering their residual ridge. There was no statistically 
significant difference between the two study centers regarding the demographic 
characteristics and risk factors associated with denture stomatitis, except for gender, 
income, educational level, denture cleanliness, and the mean age of the current 
prostheses. The Brazilian participants had more women enrolled in the trial, less income, 
lower education, and finally, older and less clean upper prostheses than the Canadian 
participants (Tables 3.2 and 3.3).  
At T0, 6.3 % of the participants had petechiae (Type IA), 16.7 % had localized 
inflammation (Type IB), 39.6 % had generalized palatal inflammation (Newton Type II) 
and finally, 37.5 % had hyperplasic inflammation (Type III). Also, 16.7 % of the 
participants had an inflammation extending up to 25 % of the palate, 33.3 % had an 
inflammation covering between 25 % and 50 % of the palate and 50 % of the participants 
had an inflammation covering more than 50 % of the palatal denture-bearing area (area of 
inflammation index). In addition, 25 % of the participants had a mild inflammation, 43.8 
% had moderate inflammation and 31.3 % had a severe inflammation (severity of the 
inflammation index).  
The microbiological analysis of the denture sonicates at T0 revealed that 39 participants 
were Candida carriers. Candida albicans was the most frequent species isolated (59 % of 
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the cultures from the denture sonicates). Other species included C. glabrata, C. krusei, 
C. tropicalis and C. parapsilosis. The cultures were negative in 9 patients (18.8 %) 
including patients classified as Type IA, Type IB and Type II. Cultures from the palatal 
swab were negative in 77 % of the cultures.  
There was no statistically significant difference between the two research centers 
according to the frequency of different types of denture stomatitis, and Candida carriage 
at baseline. 
There were no statistically significant changes in results at 1-month follow-up (T1). At 
3-month follow-up (T2), denture stomatitis was cured in 10.4 % of the participants, and 
70.8 % showed substantial improvement in the clinical signs of denture stomatitis. There 
was a worsening of the clinical signs of denture stomatitis in only one participant 
(Figure 3.2). There was a significant inflammation decrease according to the modified 
Newton classification (p = 0.001), and the area (p < 0.0001) and severity (p < 0.0001) of 
inflammation indices at 3-month follow-up. The reduction in the total score value of the 
inflammation was also significant (p < 0.0001) (Table 3.4 and Figure 3.3). Subgroup 
analyses showed that there was no change in the inflammation indices for patients with 
Type IA. Patients with Type II and III denture stomatitis showed a significant decrease 
in the total inflammation score (p < 0.0001). However, the hyperplasic tissue remained 
in all patients affected by Type III denture stomatitis.  
The effect size ranged from medium to large (0.34 to 0.54), depending on the 
classification used (Table 3.4). In addition, statistically significant improvements in the 
perceived oral condition of the participants (p = 0.003) and palatal burning sensation (p = 
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0.008) were found at 3-month follow-up. Overall, 40 % of the participants reported 
minor side effects of palatal brushing such as mild pain and some bleeding during the first 
days of treatment.  
There was no statistically significant difference between the centers regarding the 
treatment effect. However, there was a statistically significant difference between the two 
centers regarding the reported side effects of palatal brushing (p < 0.0001), with the 
majority of reported side effects occurring in the Brazilian center.  
Microbiological analyses showed a significant reduction in the number of CFUs of 
Candida isolated from denture plaque sonicates (p = 0.05) and from the palatal swabs (p 
= 0.048) at the 3-month follow-up (Table 3.5).  
Bivariate analyses did not reveal any statistically significant association between 
explanatory variables and treatment effect. 
DISCUSSION  
To our knowledge, this is the first phase-I clinical trial which provided data on the 
efficacy of the palatal brushing on denture stomatitis. The results of this study confirmed 
our previous reports on the positive effect of palatal brushing. In a recent observational 
study 
28
, we demonstrated that the chance of the remission of denture stomatitis was 3.9 
times higher in participants who brushed their palate (RR = 3.9, 95 % CI 1.0 to 15.9, p = 
0.04). Furthermore, we have shown that there is an association between the lack of 
palatal brushing and the occurrence of C. albicans (OR = 1.8, 95 % CI 1.3 to 2.4, p = 
0.03) 
8
. 
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Several mechanisms could explain the effect of palatal brushing, including mechanical 
stimulation and oral biofilm removal 
30
. An oral biofilm is a protective niche that may 
harbor a wide array of pathogenic microorganisms encased in extracellular 
polysaccharide matrix, including aerobic and anaerobic bacteria, and yeasts  
31, 32
. There 
is overwhelming evidence that denture and palate biofilms are important risk factors for 
denture stomatitis 
5, 33-35
. Palatal brushing could eliminate this reservoir of pathogens and 
the source of irritation. This could justify the statistically significant decrease in Candida 
CFUs that was demonstrated in our study. 
The results of several studies demonstrated that mechanical stimulation encourages 
keratinisation, reduces the infiltration of inflammatory cells and enhances the 
proliferation of fibroblasts and collagen synthesis 
30, 36-38
. It has been shown that even in 
the presence of oral biofilm, brushing stimulation with techniques such as vibration 
motion can improve the tissue microcirculation 
39
. Consequently, the effects of 
mechanical stimulation could counteract the effects of the inflammatory process in 
denture stomatitis. This resolution could lead to the re-establishment of an undamaged 
epithelium and basement membrane within the palatal mucosa. This healthy mucosa 
then serve as a mechanical barrier against microbiological colonization 
40, 41
.  
Impaired salivary flow and xerostomia have been considered as predisposing factors in 
denture stomatitis 
42, 43
. Palatal brushing could increase salivary flow by mechanical 
stimulation of the minor salivary glands of the palate. The stimulation of the salivary 
glands could have a mechanical cleansing effect and thus eliminate the denture biofilm 
32, 40, 44
. In addition, saliva acts as an immune defence mechanism against 
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microorganisms 
45
. In this study, patient-reported dry mouth was the most commonly 
reported side effect of palatal brushing. However, in accordance with several studies 
46, 
47, the patients’ assessment did not correlate with the findings of the clinical 
examinations. Further research should include a more accurate assessment of 
unstimulated salivary flow to confirm these results 
47
. 
There are conflicting hypotheses on whether the inflammation in denture stomatitis is 
associated with trauma from unstable prostheses or if it results from fungal biofilm 
4, 7, 41, 
46, 48
. However, there is considerable evidence demonstrating the lack of a direct cause-
and-effect relationship between the presence of denture stomatitis and Candida 
7, 8, 12
. 
Furthermore, several studies on the efficacy of antifungal medications in the treatment of 
denture stomatitis demonstrated a high recurrence rate of clinical signs of denture 
stomatitis and the re-colonization of the Candida after cessation of the antifungal 
treatment 
13, 14
. Our study results support the previous hypothesis that trauma is a 
primary etiologic factor in denture stomatitis. Thus, we encourage oral healthcare 
professionals to use conservative approaches such as oral hygiene instructions, palatal 
brushing, and prosthesis adjustments rather than antifungal medications in the treatment 
of denture stomatitis.  
In this study, we used a modified version of the Newton classification 
16
. This 
modification introduced two subtypes for Newton's Type I denture stomatitis and 
allowed us to differentiate palatal petechiae (Type IA) from localized inflammation 
(Type IB). Our findings demonstrated a difference between these two different clinical 
manifestations. The microbiologic analyses of the dentures and palatal swabs of the 
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participants with Type IA denture stomatitis were negative for the presence of Candida. 
Furthermore, petechiae remained after palatal brushing. These results suggest that 
petechiae are merely the widening of the minor salivary glands ducts, which could be 
considered as a variation of the normal anatomy caused by trauma from the denture, and 
not a pathological sign of denture stomatitis 
4, 49
. 
We also found that the use of the area and severity of the inflammation indices 
17, 50
 
permit a better classification of the clinical signs of denture stomatitis than the Newton 
classification. We recommend the use of these indices in clinical and research training to 
ensure the standardization of the methods and comparisons between trials. 
The results of this study should be interpreted with caution since a one-group pre-
test/post-test design was used, and the study did not include any control group. The 
encouraging results of this study should be confirmed by a phase-II clinical trial. 
CONCLUSION 
In conclusion, the results of this study suggest that palatal brushing is effective in the 
treatment of denture stomatitis. We recommend the use of palatal brushing as a crucial 
adjunct to the routine management of this condition. 
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                                  Figure 3.1: Flow chart of the study 
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Pre-treatment data collection (T0) 
Total n=48 
Canada n=22              Brazil n=26 
 
 
 
 
 n=95 individuals excluded because failed to 
meet the inclusion criteria: 
- No denture stomatitis (n=69) 
- Partial edentulism (n=5) 
- Use of antiobiotics/corticosteroids/ 
radiotherapy (n=8) 
- Uncontrolled diabetes mellitus (n=6) 
- Oral lesions (n=3) 
- Unavailable for follow-up appointments 
(n=4) 
 
Post-treatment data collection:   
3-month follow-up (T2) 
Total n=48 
Canada n= 22            Brazil n=26 
 
 
Post-treatment data collection: 
one-month follow-up (T1) 
Total n=48 
Canada n= 22              Brazil n=26 
 
Recruitment and 
Signature of consent form 
Total n=48 
Canada n=22              Brazil n=26 
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Table 3.1: Assessments of denture stomatitis  
Modified Newton classification 
18
 
0: Healthy mucosa 
Type IA: Petechiae in a normal palatal tissue, which are usually found around the orifices of the 
ducts of the palatal mucous glands  
Type IB: Localized area of inflammation of the denture-bearing area 
Type II: Generalised area of inflammation of the denture-bearing area 
Type III: Hyperplasic palatal surface with inflammation of the denture-bearing area 
Inflammation area index 
19
  
0: No inflammation  
1: Inflammation of the palate extending up to 25 % of the palatal denture-bearing tissue  
2: Inflammation of the palate extending between 25 % and 50 % of the palatal denture-bearing 
tissue 
3: Inflammation covering more than 50 % of the palatal denture-bearing tissue 
Inflammation severity index 
19 
0: Normal tissue  
1: Mild inflammation (slight redness, no swelling or edema) 
2: Moderate inflammation (redness with some edema)  
3: Severe inflammation (acutely inflamed redness, edema) 
Total score for inflammation = area+intensity (range 0 to 6) 
19
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Table 3.2: Socio-demographic characteristics of the participants at baseline (T0) by study center 
Variables   Combined  Canada Brazil p value 
Mean Age (years)
†
 66.0 (±11.2) 64.6 (±12.3) 67.3 (±10.2) 0.407 
 N               %    N              % N              %  
Gender 
 Male 
 
 Female 
 
16             33.3 
32             66.7 
 
  12             54.5 
  10             45.5 
 
 4             15.4 
22        84.6 
 
0.006 
Marital status 
 Single/Separated/Divorced/ 
Widowed 
 Married/Partnered 
 
23             47.9 
 
25             52.1 
 
   9               41 
 
  13              59 
 
14            53.8 
 
12            46.2 
 
0.401 
 
Living arrangements 
 Alone 
 
 With family or other adults                        
 
 8              16.7 
40             83.3 
 
    5              22.7 
  17             77.3 
 
 3             11.5 
23            88.5 
 
0.442 
Education 
 High school or less 
 
 College and higher 
 
39             81.3 
 9              18.7 
 
  13              59 
   9               41 
 
26             100 
 0                 0 
 
<0.0001 
Yearly income 
 
 Less than $10,000  
 
 $10,000 -$30,000  
 
 $30,000 or more 
   
    14             29.2 
    25             52.1 
 9              18.8 
     
    0                0 
  14             63.6 
   8              36.4 
    
   14             53.8 
11             42.3 
 1               3.8  
 
<0.0001  
† Mean (standard deviation) 
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Table 3.3: Study participants’ profiles by study center at baseline (T0) according to denture stomatitis 
risk factors  
Variables Combined Canada Brazil p value 
Mean years of edentulism
†
 37.2 (±14.7) 40.55 (±15.92) 34.3 (±13.3) 0.146 
Mean age of current prosthesis (years)
†
 15.3 (±13.7) 9.93 (±9.53) 19.8 (±15.1) 0.011 
 N               %   N            % N              %  
Presence of systemic diseases 31             64.6  12           54.5 19           73.1 0.232 
Medications use 36             75.0  17          77. 3   29           73.1 1.000 
Unacceptable VDO 30             62.5  13            59   17           65.4 0.558 
Inadequate upper retention      17             35.4   9             41    8            30.8 0.551 
Unstable upper denture      22             45.8   12           54.5   10           38.5 0.384 
Inadequate denture hygiene (reported by the 
patient) 
 5              10.4   4            18.2   1             3.8 0.165 
Dirty denture (reported by the clinician) 39             81.3   13            59 26           100 <0,0001 
No mouthwash use 35             72.9  13            59 22           84.6 0.059 
Nocturnal wear (upper denture) 28             58.3  12           54.5  16           61.5 0.770 
Smoking  13             27.1    6            27.3  7            26.9 1.000 
† Mean (standard deviation) 
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Table 3.4: Effect of the intervention at 3-month follow-up 
Diagnosis worse unchanged  improved/cured p value 
(T0-T2) 
Effect size
† 
(T0-T2) 
    N          %       N           %   N                %   
Modified Newton classification     1           2.1   32          66.6     15              31.3 0.001 0.34 
Inflammation area index     1           2.1   18          37.5     29              60.4 <0.0001 0.49 
Inflammation intensity index     1           2.1   15          31.2     32              66.7 <0.0001 0.52 
Total inflammation (area+intensity)     1           2.1    8           16.7     39              81.2 <0.0001 0.54 
† Effect size: 0.1= small effect, 0.3=medium effect and 0.5=large effect 
 
 
 
Table 3.5: Effect of the intervention on the number of Candida colonies at 3-month follow-up 
Candida colonies counts  
 
increased unchanged decreased p value 
(T0-T2) 
Effect size
†  
(T0-T2) 
    N          %       N            %   N           %   
Number of CFUs
‡
 from the prosthesis    13        27.1     7           14.6     28        58.3 0.050 0.19 
Number of CFUs
‡
 from the palate     4          8.3    34          70.8     10        20.9 0.048 0.20 
‡ Colony-forming units (CFUs)  
† Effect size: 0.1= small effect, 0.3=medium effect and 0.5=large effect 
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Figure 3.2: Treatment effect at 3-month follow-up (T2) 
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Figure 3.3: Palatal mucosa of patients at T0 and T2 
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CHAPTER IV 
DISCUSSION  
The results of this clinical trial demonstrated that palatal brushing can: 
1. Reduce the extent of palatal inflammation in individuals affected by denture 
stomatitis. 
2. Reduce the Candida colonization in the denture plaque and palate of individuals 
affected by denture stomatitis. 
4.1 PALATAL BRUSHING EFFECTS 
This master’s research project is the first clinical study specifically designed to provide 
evidence on the efficacy of palatal brushing in the treatment of denture stomatitis. 
Research on palatal brushing and its association with denture stomatitis is scarce. The 
only two observational studies that aimed to provide evidence on this simple hygienic 
measure are the previous studies of our research group 
30, 110
. One of these studies 
consisted of a university-based cohort study 
110
 that assessed the evolution of denture 
stomatitis in term of severity and frequency and its association with potential risk 
factors. 135 edentate elders wearing a set of complete dentures (either with mandibular 
denture or mandibular implant-retained overdenture) were followed over two years. The 
results showed that edentate elders suffering from type II or type III denture stomatitis 
who brushed their palate had approximately 6 times more chance to have a decrease in 
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the severity of their condition (OR = 5.88, 95 % CI 1.1 to 32.2, p = 0.04). Another 
study by Emami et al. 
30
 showed a statistically significant relationship between the lack 
of palatal brushing and the occurrence of oral candidiasis (OR = 1.8, 95 % CI 1.3 to 2.4, 
p = 0.03). 
The findings of this master’s research project confirmed the results of these previous 
studies. In the present study, after 3 months of palatal brushing, denture stomatitis was 
cured in 10.4 % of the participants, and 70.8 % showed substantial improvement in the 
clinical signs of denture stomatitis. Furthermore, there was a statistically significant 
reduction in the number of Colony-Forming Units (CFUs) of Candida isolated from the 
palatal mucosa and from the denture biofilm. However, the effect size obtained for the 
microbiological data was reported to be small to medium (r = 0.19 to 0.2), which was 
less important than the clinical effect size (r = 0.34 to 0.54).  
These promising data showed a potential success of palatal brushing in the treatment of 
denture stomatitis.  However, in our study, one participant showed an increase in palatal 
inflammation. Similarly, in participants classified with Type IA denture stomatitis (the 
presence of petechiae in a healthy mucosa), there was no change in the level of the 
modified Newton classification neither in the level of area and severity of the 
inflammation indices. Furthermore, there was no change in the Newton classification for 
the patients with Type III denture stomatitis. 
These negative results can be explained by three hypotheses: 
1. The non-compliance to intervention. This hypothesis can be specifically 
attributed to the only patient with increased inflammation after palatal brushing.   
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2. The misconception about Type I denture stomatitis. The findings of the present 
study suggest that petechiae should not be considered as a type of denture 
stomatitis since it could be simply a variation in the normal anatomy of the minor 
salivary gland openings. This hypothesis can be supported by the fact that in our 
study, the microbiological analyses of the dentures and palatal swabs of 
individuals with petechiae did not show any trace of Candida colonization. 
 
3. The shortcoming of conservative methods in the management of papillary 
hyperplasia of the palate, or Type III denture stomatitis. Hyperplasia is a reactive 
tissue overgrowth characterized by an inflamed mucosa with a nodular or 
papillary appearance in response to chronic irritation 
72, 179
. The results of the 
present study support findings in the literature suggesting that treatment of Type 
III denture stomatitis should consist of the excision of the hyperplasic tissue 
180, 
181
. However, our findings showed that there was a statistically significant 
decrease in the extent and the severity of the inflammation in the individuals with 
Type III denture stomatitis, even though the hyperplasic tissue remained. This 
finding confirms the efficacy of palatal brushing in reducing the inflammation 
associated with denture stomatitis.  
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4.2 MECHANISM OF ACTION OF PALATAL BRUSHING  
Palatal brushing can have two separate effects on the palatal mucosa: the effect of the 
mechanical stimulation and the effect of biofilm removal, both of which can lead to a 
reduction in the inflammation (Figure 4.1) 
182
. 
Mechanical stimulation improves the microcirculation of an inflamed tissue by dilation 
of the vasculature. This action leads to an increased blood flow and oxygenation of the 
tissue 
183
. Moreover, mechanical stimulation encourages keratinisation, reduces the 
infiltration of polymorphonuclear leukocytes 
182
 and enhances the proliferation and 
collagen synthesis of fibroblasts 
184-186
. The process of action of the mechanical stimulus 
will decrease or inhibit the inflammatory reaction and will lead to the resolution of the 
inflammation. This resolution allows the re-establishment of undisrupted stratified 
squamous epithelium and basement membrane that provide an impervious mechanical 
barrier against microbiological colonization and permit the restitution of a healthy 
palatal mucosa under a removable denture 
62, 65, 187, 188
.  
The mechanical stimulus can also increase the salivary flow by stimulating the minor 
salivary glands of the palate. This stimulation could have a mechanical cleansing effect 
and thus, contribute to the elimination of the biofilm 
85, 187, 189
. Saliva also has an 
immune defence mechanism against microorganisms 
190
.  
Palatal brushing also eliminates of the oral biofilm, which is considered as an etiologic 
factor for denture stomatitis 
6, 32, 34, 48
. As previously stated in Chapter I, oral biofilm acts 
as a protective niche that harbours a wide array of pathogenic microorganisms 
83, 85
. 
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Those microorganisms produce toxins and metabolic waste, which can instigate the 
inflammatory process in denture stomatitis 
6, 32, 34, 48, 83, 84
. 
Palatal brushing can eliminate this source of irritation and this reservoir of pathogens. 
This could explain the statistically significant decrease in Candida CFUs isolated from 
the palate and the dentures after 3 months of palatal brushing. 
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                                                      Figure 4.1: Palatal brushing effects 
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4.3   THE   ETIOLOGY   OF   DENTURE-RELATED   ERYTHEMATOUS 
STOMATITIS  
The etiology of denture-related erythematous stomatitis is still controversial; the 
literature offers conflicting results on whether the inflammation in denture stomatitis is 
associated with trauma from unstable prostheses or if it results from the fungal biofilm 
7, 
25, 65, 191
.  
The lack of a direct cause-and-effect relationship between the presence of denture 
stomatitis and Candida has been demonstrated in many studies 
7, 18, 30
. In addition, no 
difference between antifungal medications and alternative treatments of denture 
stomatitis were found 
26, 78, 108
. Moreover, high recurrence rates of denture stomatitis and 
the re-establishment of the Candida colonization after cessation of the antifungal 
treatment have been frequently reported 
78, 80
.  
There is considerable evidence supporting the hypothesis of trauma as a primary 
etiologic factor in denture stomatitis 
7, 13, 26, 27, 29
. The histopathological changes that 
occur in denture stomatitis, such as incomplete or absent keratinisation, and 
modifications in components and structure of the epithelium and connective tissue, in 
addition to dissociations in the basement membrane, suggest that traumatogenic stress 
from unstable dentures results in an inflammatory reaction. This reaction will increase 
the susceptibility of the palatal mucosa to microbiological colonization 
62, 63, 65
. 
Based on this concept we could hypothesize that Candida is not a primary etiologic 
factor of denture stomatitis 
7, 18, 25
 and that fungal infection contributes to the 
maintenance of the inflammatory reaction rather than its initiation 
25, 63, 65
. 
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4.4  MODIFICATION TO THE CLASSIFICATION OF DENTURE-RELATED 
ERYTHEMATOUS STOMATITIS  
In the present study, we modified the Newton classification by adding two subtypes for 
Newton's Type I denture stomatitis. This modification allowed the differentiation 
between petechiae (Type IA) and localized inflammation (Type IB) in terms of the effect 
of treatment (as mentioned in section 4.1).  
Newton classification is the most frequently used classification for the diagnosis of 
denture stomatitis in research and clinical settings. However, this classification does not 
allow an accurate representation of the clinical signs of denture stomatitis. In this 
clinical trial, we used the area and severity of the inflammation indices to account for 
this limitation. We found that this classification, which was introduced by Schwartz et 
al. 
26
, is easy to use in clinical settings and is sensitive enough to measure the effects of 
treatment. The inter-rater reliability results (kappa measurements) were higher with the 
use of those indices (κ = 0.71 to 0.86) when compared to the classification of Newton (κ 
= 0.60 to 0.84). 
4.5 ORAL HEALTH KNOWLEDGE 
Hygienic measures are essential to ensure a healthy mucosa under removable dentures. 
Those measures include: daily cleaning of the dentures by brushing after every meal, 
using a mouthwash, soaking the prosthesis in a denture-cleaning agent, and avoiding 
nocturnal wear of the dentures 
192
. However, only one study included palatal brushing 
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among other hygienic instructions given to the participants 
108
 and there was no study 
assessing the effects of palatal brushing as an intervention. 
In the present study, only 18.7 % of the participants had a clean prosthesis. Only 20 % of 
participants reported having previously received oral and denture hygiene instructions 
from their oral health care provider. Furthermore, half of the participants stated that they 
never consult a dental health care professional. There was a significant difference (p < 
0.0001) between the two centers regarding the prosthesis hygiene of the participants. 
This result could be influenced by the lower level of income and education of the 
Brazilian participants when compared to the Canadian participants. In fact, none of the 
Brazilian participants were using mouthwash as a hygienic method. However, although 
these differences between the two centers were statistically significant, they did not have 
any influence on the treatment effects.  
In agreement with the literature 
32, 193
, these findings suggest that edentate elders lack the 
necessary education about oral and denture hygiene. Oral health knowledge deficiency 
could play an important role in the prevalence of oral diseases such as denture stomatitis. 
It is the responsibility of the clinicians to raise awareness about oral hygiene and the 
necessity of periodic follow-up visits. The importance of oral health knowledge is more 
evident when taking into account the increase in the life expectancy and worldwide 
growth of the elderly population in the next decade 
48, 194, 195
. This growing geriatric 
population is more susceptible to denture-related oral mucosal lesions due to the long-
term use of removable prostheses, especially elders with systemic diseases and those 
who use multiple medications 
38-42
.  
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Palatal brushing could be an effective preventive measure against the development of 
denture stomatitis. However, it should be noted that this mode of prevention or treatment 
would be difficult for elderly patients with lack of manual dexterity 
32, 117, 196
. Alternative 
hygienic methods that could be considered for this population could be the use of 
denture cleaners, oral mouthwashes, phytomedicines, and the microwave disinfection of 
the prosthesis 
106, 128, 137, 197
. 
4.6  THE  CHOICE  OF  STUDY  DESIGN  AND  LESSON  LEARNED  FROM 
INTERNATIONAL  COLLABORATION  
Clinical trials are conducted in a series of phases and each phase is designed to achieve 
different objectives. Phase-I trials are conducted to test a first-time intervention or 
treatment in a small group of individuals in order to 
198-200
: 
1. Standardize the study procedures; 
2. Assess the safety of the intervention; 
3. Assess the recruitment strategies; 
4. Collect preliminary data on the treatment effect for sample size calculations; 
5. Assess the practicability of an international collaboration; 
6. Guide the planning of a large-scale trial. 
The evaluation of the feasibility of the collaboration between the two study centers was 
an important aspect of this master research project. In order to coordinate all the 
methodological aspects of the study and to interpret the results, three meetings between 
the research groups were organized, two in Brazil and one in Canada. 
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During the course of this study, we found that the standardization of the methodology is 
a critical step in multi-center trials. This ensures the adequacy of data for combined 
statistical analyses. 
4.7 STUDY LIMITATIONS  
The results of this phase-I clinical trial should be interpreted with caution because of 
certain study limitations. The primary threat to the internal validity of this research 
project was its design as a single group pre-test/post-test quasi-experimental study. This 
design comprises a variety of biases: 
1. History bias: the possibility that events other than the treatment could have 
happened between the pre-test and the post-test and could have affected the 
outcome;  
2.  Maturation bias: the natural process that leads participants to change as a function 
of the passage of time.  
History and maturation biases occur primarily because of the absence of a control 
group and lack of randomization 
201
.  
3. Pre-test effects: the information that participants acquire during the pre-test 
information session could influence the outcome of the study 
202
. During this 
project, the pre-test clinical examination could have sensitized the participants to 
the presence of a pathologic lesion in their oral cavity. As a result, although they 
were asked to keep to their routine hygiene regimen, they could have altered their 
behavior by improving their oral hygiene because they are taking part in an 
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experiment. This effect, also called the Hawthorne effect, could have led to an 
overestimation of the study results 
201-204
. 
Furthermore, although this project was a two-center study with a diverse population in 
term of socioeconomic and educational level, and denture characteristics (denture 
cleanliness, the mean age of the current prostheses), the study was limited in terms of 
external validity and the results cannot be generalized to other populations.  
In addition, we cannot generalize the study results across time because of the duration of 
the follow-up. In our trial, the follow-up data was collected only after 1 month and 3 
months. Therefore, we couldn’t assess the long-term effect of palatal brushing and the 
potential for the recurrence of denture stomatitis.  
4.8 FUTURE RESEARCH 
In order to develop clinical practice guidelines in regard to the treatment of denture 
stomatitis, high-quality randomized controlled trials are needed 
205
. The encouraging 
results of this master research project will help in the development of a randomized 
controlled trial with valid and generalizable results.  
Also, as the etiology of denture stomatitis is still subject to debate, we need well-
designed long-term cohort studies to shed light on the main causal factor of this disease. 
Inferences about cause-effect relationships may be valid or generalized to other 
populations only in the presence of a strong and direct relationship between the 
etiological factor and denture stomatitis, based on experimental evidence 
206
. 
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Furthermore, diagnostic studies should focus on investigating the salivary or systemic 
biomarkers involved in denture stomatitis.  
As recent studies suggest that denture-related erythematous stomatitis has cytotoxic 
effects on the cells of the oral mucosa and induce nuclear alterations 
71
, further research 
should be conducted to assess the cytotoxic and premalignant changes occurring in 
denture stomatitis. 
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CHAPTER V 
CONCLUSIONS 
The results of this phase-I clinical trial suggest that:  
1. Palatal brushing is an effective method for the treatment of denture 
stomatitis. 
2. Palatal brushing reduces the extent and severity of the palatal inflammation 
in individuals affected by denture stomatitis. 
3. Palatal brushing reduces the number of Candida Colony-Forming Units 
(CFUs) present in the denture biofilm and palate of individuals affected by 
denture stomatitis. 
4. The encouraging results of this phase-I clinical trial should be confirmed by 
a phase-II clinical trial. 
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